Pesticidal compositions and related methods
09549560 ยท 2017-01-24
Assignee
Inventors
- MARTIN J. WALSH (CARMEL, IN, US)
- Daniel Knueppel (Zionsville, IN, US)
- Noormohamed M. Niyaz (Indianapolis, IN)
- Ann M. Buysse (Carmel, IN)
- Negar Garizi (Westfield, IN)
- Asako Kubota (Indianapolis, IN, US)
- Yu Zhang (Carmel, IN)
- Ricky Hunter (Westfield, IN)
- Tony K. Trullinger (Westfield, IN)
Cpc classification
C05G3/60
CHEMISTRY; METALLURGY
International classification
Abstract
A pesticidal composition comprises at least one compound selected from a 1-(3-pyridyl-N-oxide) pyrazole compound of formula I, II, or III, or any agriculturally acceptable salt thereof, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.12, R.sub.13, Y, and Q, are as described herein. A method of controlling pests comprises applying the pesticidal composition near a population of pests. ##STR00001##
Claims
1. A pesticidal composition, comprising 1-(3-pyridyl-N-oxide)pyrazole compound of formula I or any agriculturally acceptable salt thereof: ##STR00268## wherein: (a) R.sub.1, R.sub.2, and R.sub.4 are independently selected from H, F, Cl, Br, I, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, or substituted or unsubstituted C.sub.1-C.sub.6 haloalkyl, wherein each said R.sub.1, R.sub.2, and R.sub.4, when substituted, has one or more substituents selected from F, Cl, Br, I, CN, NO.sub.2, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.1-C.sub.6 haloalkyl, C.sub.3-C.sub.10 cycloalkyl, or C.sub.3-C.sub.10 halocycloalkyl, each of which is substituted, unsubstituted, or substituted with R.sub.11; (b) R.sub.3 is selected from H, F, Cl, Br, I, CN, NO.sub.2, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, substituted or unsubstituted C.sub.2-C.sub.6 alkenyl, substituted or unsubstituted C.sub.1-C.sub.6 alkoxy, substituted or unsubstituted C.sub.3-C.sub.10 cycloalkyl, substituted or unsubstituted C.sub.1-C.sub.6 haloalkyl, substituted or unsubstituted C.sub.6-C.sub.20 aryl, substituted or unsubstituted C.sub.1-C.sub.20 heterocyclyl, OR.sub.11, C(X.sub.1)R.sub.11, C(X.sub.1)OR.sub.11, C(X.sub.1)N(R.sub.11).sub.2, N(R.sub.11).sub.2, N(R.sub.11)C(X.sub.1)R.sub.11, SR.sub.11, S(O).sub.nOR.sub.11, or R.sub.11S(O).sub.nR.sub.11, wherein each said R.sub.3, when substituted, has one or more substituents selected from F, Cl, Br, I, CN, NO.sub.2, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.1-C.sub.6 haloalkyl, C.sub.2-C.sub.6 haloalkenyl, C.sub.1-C.sub.6 haloalkyloxy, C.sub.2-C.sub.6 haloalkenyloxy, C.sub.3-C.sub.10 cycloalkyl, C.sub.3-C.sub.10 cycloalkenyl, C.sub.3-C.sub.10 halocycloalkyl, C.sub.3-C.sub.10 halocycloalkenyl, OR.sub.11, S(O).sub.nOR.sub.11, C.sub.6-C.sub.20 aryl, or C.sub.1-C.sub.20 heterocyclyl, each of which is substituted, unsubstituted, or substituted with R.sub.11; (c) R.sub.5 is H, F, Cl, Br, I, CN, NO.sub.2, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, substituted or unsubstituted C.sub.2-C.sub.6 alkenyl, substituted or unsubstituted C.sub.1-C.sub.6 alkoxy, C.sub.3-C.sub.10 cycloalkyl, substituted or unsubstituted C.sub.6-C.sub.20 aryl, substituted or unsubstituted C.sub.1-C.sub.20 heterocyclyl, OR.sub.11, C(X.sub.1)R.sub.11, C(X.sub.1)OR.sub.11, C(X.sub.1)N(R.sub.11).sub.2, N(R.sub.11).sub.2, N(R.sub.11)C(X.sub.1)R.sub.11, SR.sub.11, S(O).sub.nOR.sub.11, or R.sub.11S(O).sub.nR.sub.11, wherein each said R.sub.5, when substituted, has one or more substituents selected from F, Cl, Br, I, CN, NO.sub.2, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.1-C.sub.6 haloalkyl, C.sub.2-C.sub.6 haloalkenyl, C.sub.1-C.sub.6 haloalkyloxy, C.sub.2-C.sub.6 haloalkenyloxy, C.sub.3-C.sub.10 cycloalkyl, C.sub.3-C.sub.10 cycloalkenyl, C.sub.3-C.sub.10 halocycloalkyl, C.sub.3-C.sub.10 halocycloalkenyl, OR.sub.11, S(O).sub.nOR.sub.11, C.sub.6-C.sub.20 aryl, or C.sub.1-C.sub.20 heterocyclyl, each of which is substituted, unsubstituted, or substituted with R.sub.11; (d) R.sub.6 is H, F, Cl, Br, I, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, or C.sub.1-C.sub.6 haloalkyl, wherein each said R.sub.6, when substituted, has one or more substituents selected from F, Cl, Br, I, CN, NO.sub.2, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.1-C.sub.6 haloalkyl, C.sub.2-C.sub.6 haloalkenyl, C.sub.1-C.sub.6 haloalkyloxy, C.sub.2-C.sub.6 haloalkenyloxy, C.sub.3-C.sub.10 cycloalkyl, C.sub.3-C.sub.10 cycloalkenyl, C.sub.3-C.sub.10 halocycloalkyl, or C.sub.3-C.sub.10 halocycloalkenyl; (e) R.sub.7 is selected from H, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, substituted or unsubstituted C.sub.2-C.sub.6 alkenyl, substituted or unsubstituted C.sub.2-C.sub.6 alkynyl, substituted or unsubstituted C.sub.1-C.sub.6 alkoxy, substituted or unsubstituted C.sub.3-C.sub.10 cycloalkyl, substituted or unsubstituted C.sub.6-C.sub.20 aryl, substituted or unsubstituted C.sub.1-C.sub.20 heterocyclyl, C.sub.1-C.sub.6 alkyl C.sub.6-C.sub.20 aryl wherein the alkyl and aryl is independently substituted or unsubstituted, C.sub.1-C.sub.6 alkyl-(C.sub.3-C.sub.10 cyclohaloalkyl) wherein the alkyl and cyclohaloalkyl is independently substituted or unsubstituted, C.sub.1-C.sub.6 alkyl-(C.sub.3-C.sub.10 cycloalkyl) wherein the alkyl and cycloalkyl is independently substituted or unsubstituted, wherein each said R.sub.7, when substituted, has one or more substituents selected from F, Cl, Br, I, CN, NO.sub.2, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 haloalkyl, C.sub.2-C.sub.6 haloalkenyl, C.sub.1-C.sub.6 haloalkyloxy, C.sub.2-C.sub.6 haloalkenyloxy, C.sub.3-C.sub.10 cycloalkyl, C.sub.3-C.sub.10 cycloalkenyl, C.sub.3-C.sub.10 halocycloalkyl, C.sub.3-C.sub.10 halocycloalkenyl, OR.sub.11, S(O).sub.nOR.sub.11, C.sub.6-C.sub.20 aryl, or C.sub.1-C.sub.20 heterocyclyl, or R.sub.11aryl, each of which is substituted, unsubstituted, or substituted with R.sub.11; (f) R.sub.8 is R.sub.9S(O).sub.nR.sub.10 or R.sub.9S(O).sub.nH; (g) R.sub.9 is substituted or unsubstituted C.sub.2-C.sub.12 alkenyl, substituted or unsubstituted C.sub.1-C.sub.12 alkyl, or substituted or unsubstituted C.sub.3-C.sub.10 cycloalkyl, wherein each said R.sub.9, when substituted, has one or more substituents selected from F, Cl, Br, I, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.1-C.sub.6 haloalkyl, C.sub.3-C.sub.10 cycloalkyl, C.sub.3-C.sub.10 halocycloalkyl, OR.sub.11, S(O).sub.nR.sub.11, C.sub.6-C.sub.20 aryl, or C.sub.1-C.sub.20 heterocyclyl, each of which is substituted, unsubstituted, or substituted with R.sub.11; (h) R.sub.10 is selected from substituted or unsubstituted C.sub.1-C.sub.6 alkyl, substituted or unsubstituted C.sub.2-C.sub.6 alkenyl, substituted or unsubstituted C.sub.1-C.sub.6 alkoxy, substituted or unsubstituted C.sub.3-C.sub.10 cycloalkyl, substituted or unsubstituted C.sub.3-C.sub.10 halocycloalkyl substituted or unsubstituted C.sub.3-C.sub.10 cycloalkenyl, substituted or unsubstituted C.sub.6-C.sub.20 aryl, or substituted or unsubstituted C.sub.1-C.sub.20 heterocyclyl, wherein each said R.sub.10, when substituted, has one or more substituents selected from F, Cl, Br, I, CN, NO.sub.2, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.1-C.sub.6 haloalkyl, C.sub.2-C.sub.6 haloalkenyl, C.sub.1-C.sub.6 haloalkyloxy, C.sub.2-C.sub.6 haloalkenyloxy, C.sub.3-C.sub.10 cycloalkyl, C.sub.3-C.sub.10 cycloalkenyl, C.sub.3 -C.sub.10 halocycloalkyl, C.sub.3-C.sub.10 halocycloalkenyl, oxo, OR.sub.11, S(O).sub.nR.sub.11, C.sub.6-C.sub.20 aryl, or C.sub.1-C.sub.20 heterocyclyl, each of which is substituted, unsubstituted, or substituted with R.sub.11; (i) R.sub.11 is, each independently, selected from H, R.sub.8, CN, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, substituted or unsubstituted C.sub.2-C.sub.6 alkenyl, substituted or unsubstituted C.sub.1-C.sub.6 alkoxy, substituted or unsubstituted C.sub.2-C.sub.6 alkenyloxy, substituted or unsubstituted C.sub.3-C.sub.10 cycloalkyl, substituted or unsubstituted C.sub.3-C.sub.10 cycloalkenyl, substituted or unsubstituted C.sub.6-C.sub.20 aryl, substituted or unsubstituted C.sub.1-C.sub.20 heterocyclyl, substituted or unsubstituted S(O).sub.nC.sub.1-C.sub.6 alkyl, or substituted or unsubstituted N(C.sub.1-C.sub.6 alkyl).sub.2, wherein each said R.sub.11, when substituted, has one or more substituents selected from F, Cl, Br, I, CN, NO.sub.2, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.1-C.sub.6 haloalkyl, C.sub.2-C.sub.6 haloalkenyl, C.sub.1-C.sub.6 haloalkyloxy, C.sub.2-C.sub.6 haloalkenyloxy, C.sub.3-C.sub.10 cycloalkyl, C.sub.3-C.sub.10 cycloalkenyl, C.sub.3-C.sub.10 halocycloalkyl, C.sub.3-C.sub.10 halocycloalkenyl, OC.sub.1-C.sub.6 alkyl, OC.sub.1-C.sub.6 haloalkyl, S(O).sub.nC.sub.1-C.sub.6 alkyl, S(O).sub.nOC.sub.1-C.sub.6 alkyl, C.sub.6-C.sub.20 aryl, or C.sub.1-C.sub.20 heterocyclyl; (j) Q is O, S or S(O).sub.n; (k) X.sub.1 is O or S; and (l) n is 0, 1 or 2.
2. The composition of claim 1, wherein R.sub.1, R.sub.2, and R.sub.4 are H.
3. The composition of claim 1, wherein R.sub.3 is selected from H, F, Cl, Br, or I.
4. The composition of claim 1, wherein R.sub.3 is H or F.
5. The composition of claim 1, wherein R.sub.5 is selected from F, Cl, Br, I, or unsubstituted C.sub.1-C.sub.6 alkyl.
6. The composition of claim 1, wherein R.sub.5 is Cl or CH.sub.3.
7. The composition of claim 1, wherein R.sub.6 is H.
8. The composition of claim 1, wherein R.sub.7 is selected from H, CH.sub.3, CH.sub.2CH.sub.3 CH.sub.2CCH, or CH(CH.sub.3)CCH.
9. The composition of claim 1, wherein R.sub.8 is selected from C.sub.1-C.sub.6 alkyl-S(O).sub.nCH.sub.2(unsubstituted C.sub.3-C.sub.10 halocycloalkyl), C.sub.1-C.sub.6 alkyl-S(O).sub.nC.sub.3-C.sub.6 haloalkyl wherein said halos are only on the carbon atom furthest from the sulfur atom.
10. The composition of claim 1, wherein R.sub.8 is selected from C.sub.1-C.sub.4 alkyl-SCH.sub.2-halocyclopropyl or CH.sub.2CH.sub.2SCH.sub.2CH.sub.2CF.sub.3.
11. The composition of claim 1, wherein n is 0 or 1.
12. The composition of claim 1, further comprising: (a) one or more compounds having acaricidal, algicidal, avicidal, bactericidal, fungicidal, herbicidal, insecticidal, molluscicidal, nematicidal, rodenticidal, or virucidal properties; or (b) one or more compounds that are antifeedants, bird repellents, chemosterilants, herbicide safeners, insect attractants, insect repellents, mammal repellents, mating disrupters, plant activators, plant growth regulators, or synergists; or (c) both (a) and (b).
13. The composition of claim 1, further comprising one or more compounds selected from: (3-ethoxypropyl)mercury bromide, 1,2-dichloropropane, 1,3-dichloropropene, 1-methylcyclopropene, 1-naphthol, 2-(octylthio)ethanol, 2,3,5-tri-iodobenzoic acid, 2,3,6-TBA, 2,3,6-TBA-dimethylammonium, 2,3,6-TBA-lithium, 2,3,6-TBA-potassium, 2,3,6-TBA-sodium, 2,4,5-T, 2,4,5-T-2-butoxypropyl, 2,4,5-T-2-ethylhexyl, 2,4,5-T-3-butoxypropyl, 2,4,5-TB, 2,4,5-T-butometyl, 2,4,5-T-butotyl, 2,4,5-T-butyl, 2,4,5-T-isobutyl, 2,4,5-T-isoctyl, 2,4,5-T-isopropyl, 2,4,5-T-methyl, 2,4,5-T-pentyl, 2,4,5-T-sodium, 2,4,5-T-triethylammonium, 2,4,5-T-trolamine, 2,4-D, 2,4-D-2-butoxypropyl, 2,4-D-2-ethylhexyl, 2,4-D-3-butoxypropyl, 2,4-D-ammonium, 2,4-DB, 2,4-DB-butyl, 2,4-DB-dimethylammonium, 2,4-DB-isoctyl, 2,4-DB-potassium, 2,4-DB-sodium, 2,4-D-butotyl, 2,4-D-butyl, 2,4-D-diethylammonium, 2,4-D-dimethylammonium, 2,4-D-diolamine, 2,4-D-dodecylammonium, 2,4-DEB, 2,4-DEP, 2,4-D-ethyl, 2,4-D-heptylamrnonium, 2,4-D-isobutyl, 2,4-D-isoctyl, 2,4-D-isopropyl, 2,4-D-isopropylammonium, 2,4-D-lithium, 2,4-D-meptyl, 2,4-D-methyl, 2,4-D-octyl, 2,4-D-pentyl, 2,4-D-potassium, 2,4-D-propyl, 2,4-D-sodium, 2,4-D-tefuryl, 2,4-D-tetradecylammonium, 2,4-D-triethylammonium, 2,4-D-tris(2-hydroxypropyl)ammonium, 2,4-D-trolamine, 2iP, 2-methoxyethylmercury chloride, 2-phenylphenol, 3,4-DA, 3,4-DB, 3,4-DP, 4-aminopyridine, 4-CPA, 4-CPA-potassium, 4-CPA-sodium, 4-CPB, 4-CPP, 4-hydroxyphenethyl alcohol, 8-hydroxyquinoline sulfate, 8-phenylmercurioxyquinoline, abamectin, abscisic acid, ACC, acephate, acequinocyl, acetamiprid, acethion, acetochlor, acetophos, acetoprole, acibenzolar, acibenzolar-S-methyl, acifluorfen, acifluorfen-methyl, acifluorfen-sodium, aclonifen, acrep, acrinathrin, acrolein, acrylonitrile, acypetacs, acypetacs-copper, acypetacs-zinc, alachlor, alanycarb, albendazole, aldicarb, aldimorph, aldoxycarb, aldrin, allethrin, allicin, allidochlor, allosamidin, alloxydim, alloxydim-sodium, allyl alcohol, allyxycarb, alorac, alpha-cypermethrin, alpha-endosulfan, ametoctradin, ametridione, ametryn, amibuzin, amicarbazone, amicarthiazol, amidithion, amidoflumet, amidosulfuron, aminocarb, aminocyclopyrachlor, amino cyclopyrachlor-methyl, aminocyclopyrachlor-potassium, aminopyralid, aminopyralid-potassium, aminopyralid-tris(2-hydroxypropyl)ammonium, amiprofos-methyl, amiprophos, amisulbrom, amiton, amiton oxalate, amitraz, amitrole, ammonium sulfamate, ammonium -naphthaleneacetate, amobam, ampropylfos, anabasine, ancymidol, anilazine, anilofos, anisuron, anthraquinone, antu, apholate, aramite, arsenous oxide, asomate, aspirin, asulam, asulam-potassium, asulam-sodium, athidathion, atraton, atrazine, aureofungin, aviglycine, aviglycine hydrochloride, azaconazole, azadirachtin, azafenidin, azamethiphos, azimsulfuron, azinphos-ethyl, azinphos-methyl, aziprotryne, azithiram, azobenzene, azocyclotin, azothoate, azoxystrobin, bachmedesh, barban, barium hexafluorosilicate, barium polysulfide, barthrin, BCPC, beflubutamid, benalaxyl, benalaxyl-M, benazolin, benazolin-dimethylammonium, benazolin-ethyl, benazolin-potassium, bencarbazone, benclothiaz, bendiocarb, benfluralin, benfuracarb, benfuresate, benodanil, benomyl, benoxacor, benoxafos, benquinox, bensulfuron, bensulfuron-methyl, bensulide, bensultap, bentaluron, bentazone, bentazone-sodium, benthiavalicarb, benthiavalicarb-isopropyl, benthiazole, bentranil, benzadox, benzadox-ammonium, benzalkonium chloride, benzamacril, benzamacril-isobutyl, benzamorf, benzfendizone, benzipram, benzobicyclon, benzofenap, benzofluor, benzohydroxamic acid, benzoximate, benzoylprop, benzoylprop-ethyl, benzthiazuron, benzyl benzoate, benzyladenine, berberine, berberine chloride, beta-cyfluthrin, beta-cypermethrin, bethoxazin, bicyclopyrone, bifenazate, bifenox, bifenthrin, bifujunzhi, bilanafos, bilanafos-sodium, binapacryl, bingqingxiao, bioallethrin, bioethanomethrin, biopermethrin, bioresmethrin, biphenyl, bisazir, bismerthiazol, bispyribac, bispyribac-sodium, bistrifluron, bitertanol, bithionol, bixafen, blasticidin-S, borax, Bordeaux mixture, boric acid, boscalid, brassinolide, brassinolide-ethyl, brevicomin, brodifacoum, brofenvalerate, brofluthrinate, bromacil, bromacil-lithium, bromacil-sodium, bromadiolone, bromethalin, bromethrin, bromfenvinfos, bromoacetamide, bromobonil, bromobutide, bromocyclen, bromo-DDT, bromofenoxim, bromophos, bromophos-ethyl, bromopropylate, bromothalonil, bromoxynil, bromoxynil butyrate, bromoxynil heptanoate, bromoxynil octanoate, bromoxynil-potassium, brompyrazon, bromuconazole, bronopol, bucarpolate, bufencarb, buminafos, bupirimate, buprofezin, Burgundy mixture, busulfan, butacarb, butachlor, butafenacil, butamifos, butathiofos, butenachlor, butethrin, buthidazole, buthiobate, buthiuron, butocarboxim, butonate, butopyronoxyl, butoxycarboxim, butralin, butroxydim, buturon, butylamine, butylate, cacodylic acid, cadusafos, cafenstrole, calcium arsenate, calcium chlorate, calcium cyanamide, calcium polysulfide, calvinphos, cambendichlor, camphechlor, camphor, captafol, captan, carbamorph, carbanolate, carbaryl, carbasulam, carbendazim, carbendazim benzenesulfonate, carbendazim sulfite, carbetamide, carbofuran, carbon disulfide, carbon tetrachloride, carbophenothion, carbosulfan, carboxazole, carboxide, carboxin, carfentrazone, carfentrazone-ethyl, carpropamid, cartap, cartap hydrochloride, carvacrol, carvone, CDEA, cellocidin, CEPC, ceralure, Cheshunt mixture, chinomethionat, chitosan, chlobenthiazone, chlomethoxyfen, chloralose, chloramben, chloramben-ammonium, chloramben-diolamine, chloramben-methyl, chloramben-methylammonium, chloramben-sodium, chloramine phosphorus, chloramphenicol, chloraniformethan, chloranil, chloranocryl, chlorantraniliprole, chlorazifop, chlorazifop-propargyl, chlorazine, chlorbenside, chlorbenzuron, chlorbicyclen, chlorbromuron, chlorbufam, chlordane, chlordecone, chlordimeform, chlordimeform hydrochloride, chlorempenthrin, chlorethoxyfos, chloreturon, chlorfenac, chlorfenac-ammonium, chlorfenac-sodium, chlorfenapyr, chlorfenazole, chlorfenethol, chlorfenprop, chlorfenson, chlorfensulphide, chlorfenvinphos, chlorfluazuron, chlorflurazole, chlorfluren, chlorfluren-methyl, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlormephos, chlormequat, chlormequat chloride, chlomidine, chlomitrofen, chlorobenzilate, chlorodinitronaphthalenes, chloroform, chloromebuform, chloromethiuron, chloroneb, chlorophacinone, chlorophacinone-sodium, chloropicrin, chloropon, chloropropylate, chlorothalonil, chlorotoluron, chloroxuron, chloroxynil, chlorphonium, chlorphonium chloride, chlorphoxim, chlorprazophos, chlorprocarb, chlorpropham, chlorpyrifos, chlorpyrifos-methyl, chlorquinox, chlorsulfuron, chlorthal, chlorthal-dimethyl, chlorthal-monomethyl, chlorthiamid, chlorthiophos, chlozolinate, choline chloride, chromafenozide, cinerin I, cinerin II, cinerins, cinidon-ethyl, cinmethylin, cinosulfuron, ciobutide, cisanilide, cismethrin, clethodim, climbazole, cliodinate, clodinafop, clodinafop-propargyl, cloethocarb, clofencet, clofencet-potassium, clofentezine, clofibric acid, clofop, clofop-isobutyl, clomazone, clomeprop, cloprop, cloproxydim, clopyralid, clopyralid-methyl, clopyralid-olamine, clopyralid-potassium, clopyralid-tris(2-hydroxypropyl)ammonium, cloquintocet, cloquintocet-mexyl, cloransulam, cloransulam-methyl, closantel, clothianidin, clotrimazole, cloxyfonac, cloxyfonac-sodium, CMA, codlelure, colophonate, copper acetate, copper acetoarsenite, copper arsenate, copper carbonate, basic, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper silicate, copper sulfate, copper zinc chromate, coumachlor, coumafuryl, coumaphos, coumatetralyl, coumithoate, coumoxystrobin, CPMC, CPMF, CPPC, credazine, cresol, crimidine, crotamiton, crotoxyphos, crufomate, cryolite, cue-lure, cufraneb, cumyluron, cuprobam, cuprous oxide, curcumenol, cyanamide, cyanatryn, cyanazine, cyanofenphos, cyanophos, cyanthoate, cyantraniliprole, cyazofamid, cybutryne, cyclafuramid, cyclanilide, cyclethrin, cycloate, cycloheximide, cycloprate, cycloprothrin, cyclosulfamuron, cycloxydim, cycluron, cyenopyrafen, cyflufenamid, cyflumetofen, cyfluthrin, cyhalofop, cyhalofop-butyl, cyhalothrin, cyhexatin, cymiazole, cymiazole hydrochloride, cymoxanil, cyometrinil, cypendazole, cypermethrin, cyperquat, cyperquat chloride, cyphenothrin, cyprazine, cyprazole, cyproconazole, cyprodinil, cyprofuram, cypromid, cyprosulfamide, cyromazine, cythioate, daimuron, dalapon, dalapon-calcium, dalapon-magnesium, dalapon-sodium, daminozide, dayoutong, dazomet, dazornet-sodium, DBCP, d-camphor, DCIP, DCPTA, DDT, debacarb, decafentin, decarbofuran, dehydroacetic acid, delachlor, deltamethrin, demephion, demephion-O, demephion-S, demeton, demeton-methyl, demeton-O, demeton-O-methyl, demeton-S, demeton-S-methyl, demeton-S-methylsulphon, desmedipham, desmetryn, d-fanshiluquebingjuzhi, diafenthiuron, dialifos, di-allate, diamidafos, diatomaceous earth, diazinon, dibutyl phthalate, dibutyl succinate, dicamba, dicamba-diglycolamine, dicamba-dimethylammonium, dicamba-diolamine, dicamba-isopropylammonium, dicamba-methyl, dicamba-olamine, dicamba-potassium, dicamba-sodium, dicamba-trolamine, dicapthon, dichlobenil, dichlofenthion, dichlofluanid, dichlone, dichloralurea, dichlorbenzuron, dichlorflurenol, dichlorflurenol-methyl, dichlormate, dichlormid, dichlorophen, dichlorprop, dichlorprop-2-ethylhexyl, dichlorprop-butotyl, dichlorprop-dimethylammonium, dichlorprop-ethylammonium, dichlorprop-isoctyl, dichlorprop-methyl, dichlorprop-P, dichlorprop-P-2-ethylhexyl, dichlorprop-P-dimethylammonium, dichlorprop-potassium, dichlorprop-sodium, dichlorvos, dichlozoline, diclobutrazol, diclocymet, diclofop, diclofop-methyl, diclomezine, diclomezine-sodium, dicloran, diclosulam, dicofol, dicoumarol, dicresyl, dicrotophos, dicyclanil, dicyclonon, dieldrin, dienochlor, diethamquat, diethamquat dichloride, diethatyl, diethatyl-ethyl, diethofencarb, dietholate, diethyl pyrocarbonate, diethyltoluamide, difenacoum, difenoconazole, difenopenten, difenopenten-ethyl, difenoxuron, difenzoquat, difenzoquat metilsulfate, difethialone, diflovidazin, diflubenzuron, diflufenican, diflufenzopyr, diflufenzopyr-sodium, diflumetorim, dikegulac, dikegulac-sodium, dilor, dimatif, dimefluthrin, dimefox, dimefuron, dimepiperate, dimetachlone, dimetan, dimethacarb, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimethipin, dimethirirnol, dimethoate, dimethomorph, dimethrin, dimethyl carbate, dimethyl phthalate, dimethylvinphos, dimetilan, dimexano, dimidazon, dimoxystrobin, dinex, dinex-diclexine, dingjunezuo, diniconazole, diniconazole-M, dinitramine, dinobuton, dinocap, dinocap-4, dinocap-6, dinocton, dinofenate, dinopenton, dinoprop, dinosaur, dinoseb, dinoseb acetate, dinoseb-ammonium, dinoseb-diolamine, dinoseb-sodium, dinoseb-trolamine, dinosulfon, dinotefuran, dinoterb, dinoterb acetate, dinoterbon, diofenolan, dioxabenzofos, dioxacarb, dioxathion, diphacinone, diphacinone-sodium, diphenamid, diphenyl sulfone, diphenylamine, dipropalin, dipropetryn, dipyrithione, diquat, diquat dibromide, disparlure, disul, disulfiram, disulfoton, disul-sodium, ditalimfos, dithianon, dithicrofos, dithioether, dithiopyr, diuron, d-limonene, DMPA, DNOC, DNOC-ammonium, DNOC-potassium, DNOC-sodium, dodemorph, dodemorph acetate, dodemorph benzoate, dodicin, dodicin hydrochloride, dodicin-sodium, dodine, dofenapyn, dominicalure, doramectin, drazoxolon, DSMA, dufulin, EBEP, EBP, ecdysterone, edifenphos, eglinazine, eglinazine-ethyl, emamectin, emamectin benzoate, EMPC, empenthrin, endosulfan, endothal, endothal-diammonium, endothal-dipotassium, endothal-disodium, endothion, endrin, enestroburin, EPN, epocholeone, epofenonane, epoxiconazole, eprinomectin, epronaz, EPTC, erbon, ergocalciferol, erlujixiancaoan, esdpallthrine, esfenvalerate, esprocarb, etacelasil, etaconazole, etaphos, etem, ethaboxam, ethachlor, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, ethaprochlor, ethephon, ethidimuron, ethiofencarb, ethiolate, ethion, ethiozin, ethiprole, ethirimol, ethoate-methyl, ethofumesate, ethohexadiol, ethoprophos, ethoxyfen, ethoxyfen-ethyl, ethoxyquin, ethoxysulfuron, ethychlozate, ethyl formate, ethyl -naphthaleneacetate, ethyl-DDD, ethylene, ethylene dibromide, ethylene dichloride, ethylene oxide, ethylicin, ethylmercury 2,3-dihydroxypropyl mercaptide, ethylmercury acetate, ethylmercury bromide, ethylmercury chloride, ethylmercury phosphate, etinofen, etnipromid, etobenzanid, etofenprox, etoxazole, etridiazole, etrimfos, eugenol, EXD, famoxadone, famphur, fenamidone, fenaminosulf, fenamiphos, fenapanil, fenarimol, fenasulam, fenazaflor, fenazaquin, fenbuconazole, fenbutatin oxide, fenchlorazole, fenchlorazole-ethyl, fenchlorphos, fenclorim, fenethacarb, fenfluthrin, fenfuram, fenhexamid, fenitropan, fenitrothion, fenjuntong, fenobucarb, fenoprop, fenoprop-3-butoxypropyl, fenoprop-butometyl, fenoprop-butotyl, fenoprop-butyl, fenoprop-isoctyl, fenoprop-methyl, fenoprop-potassium, fenothiocarb, fenoxacrim, fenoxanil, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fenoxasulfone, fenoxycarb, fenpiclonil, fenpirithrin, fenpropathrin, fenpropidin, fenpropimorph, fenpyrazamine, fenpyroximate, fenridazon, fenridazon-potassium, fenridazon-propyl, fenson, fensulfothion, fenteracol, fenthiaprop, fenthiaprop-ethyl, fenthion, fenthion-ethyl, fentin, fentin acetate, fentin chloride, fentin hydroxide, fentrazamide, fentrifanil, fenuron, fenuron TCA, fenvalerate, ferbam, ferimzone, ferrous sulfate, fipronil, flamprop, flamprop-isopropyl, flamprop-M, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, flocoumafen, flometoquin, flonicamid, florasulam, fluacrypyrim, fluazifop, fluazifop-butyl, fluazifop-methyl, fluazifop-P, fluazifop-P-butyl, fluazinam, fluazolate, fluazuron, flubendiamide, flubenzimine, flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flucofuron, flucycloxuron, flucythrinate, fludioxonil, fluenetil, fluensulfone, flufenacet, flufenerim, flufenican, flufenoxuron, flufenprox, flufenpyr, flufenpyr-ethyl, flufiprole, flumethrin, flumetover, flumetralin, flumetsulam, flumezin, flumiclorac, flumiclorac-pentyl, flumioxazin, flumipropyn, flumorph, fluometuron, fluopicolide, fluopyram, fluorbenside, fluoridamid, fluoroacetamide, fluorodifen, fluoroglycofen, fluoroglycofen-ethyl, fluoroimide, fluoromidine, fluoronitrofen, fluothiuron, fluotrimazole, fluoxastrobin, flupoxam, flupropacil, flupropadine, flupropanate, flupropanate-sodium, flupyradifurone, flupyrsulfuron, flupyrsulfuron-methyl, flupyrsulfuron-methyl-sodium, fluquinconazole, flurazole, flurenol, flurenol-butyl, flurenol-methyl, fluridone, flurochloridone, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, flurprimidol, flursulamid, flurtamone, flusilazole, flusulfamide, fluthiacet, fluthiacet-methyl, flutianil, flutolanil, flutriafol, fluvalinate, fluxapyroxad, fluxofenim, folpet, fomesafen, fomesafen-sodium, fonofos, foramsulfuron, forchlorfenuron, formaldehyde, formetanate, formetanate hydrochloride, formothion, formparanate, formparanate hydrochloride, fosamine, fosamine-ammonium, fosetyl, fosetyl-aluminium, fosmethilan, fospirate, fosthiazate, fosthietan, frontalin, fuberidazole, fucaojing, fucaomi, funaihecaoling, fuphenthiourea, furalane, furalaxyl, furamethrin, furametpyr, furathiocarb, furcarbanil, furconazole, furconazole-cis, furethrin, furfural, furilazole, furmecyclox, furophanate, furyloxyfen, gamma-cyhalothrin, gamma-HCH, genit, gibberellic acid, gibberellins, gliftor, glufosinate, glufosinate-ammonium, glufosinate-P, glufosinate-P-ammonium, glufosinate-P-sodium, glyodin, glyoxime, glyphosate, glyphosate-diammonium, glyphosate-dimethylammonium, glypho sate-isopropylammonium, glyphosate-monoammonium, glyphosate-potassium, glyphosate-sesquisodium, glyphosate-trimesium, glyphosine, gossyplure, grandlure, griseofulvin, guazatine, guazatine acetates, halacrinate, halfenprox, halofenozide, halosafen, halosulfuron, halosulfuron-methyl, haloxydine, haloxyfop, haloxyfop-etotyl, haloxyfop-methyl, haloxyfop-P, haloxyfop-P-etotyl, haloxyfop-P-methyl, haloxyfop-sodium, HCH, hemel, hempa, HEOD, heptachlor, heptenophos, heptopargil, heterophos, hexachloroacetone, hexachlorobenzene, hexachlorobutadiene, hexachlorophene, hexaconazole, hexaflumuron, hexaflurate, hexalure, hexamide, hexazinone, hexylthiofos, hexythiazox, HHDN, holosulf, huancaiwo, huangcaoling, huanjunzuo, hydramethylnon, hydrargaphen, hydrated lime, hydrogen cyanide, hydroprene, hymexazol, hyquincarb, IAA, IBA, icaridin, imazalil, imazalil nitrate, imazalil sulfate, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazaquin-methyl, imazaquin-sodium, imazethapyr, imazethapyr-ammonium, imazosulfuron, imibenconazole, imicyafos, imidacloprid, imidaclothiz, iminoctadine, iminoctadine triacetate, iminoctadine trialbesilate, imiprothrin, inabenfide, indanofan, indaziflam, indoxacarb, inezin, iodobonil, iodocarb, iodomethane, iodosulfuron, iodosulfuron-methyl, iodosulfuron-methyl-sodium, iofensulfuron, iofensulfuron-sodium, ioxynil, ioxynil octanoate, ioxynil-lithium, ioxynil-sodium, ipazine, ipconazole, ipfencarbazone, iprobenfos, iprodione, iprovalicarb, iprymidam, ipsdienol, ipsenol, IPSP, isamidofos, isazofos, isobenzan, isocarbamid, isocarbophos, isocil, isodrin, isofenphos, isofenphos-methyl, isolan, isomethiozin, isonoruron, isopolinate, isoprocarb, isopropalin, isoprothiolane, isoproturon, isopyrazam, isopyrimol, isothioate, isotianil, isouron, isovaledione, isoxaben, isoxachlortole, isoxadifen, isoxadifen-ethyl, isoxaflutole, isoxapyrifop, isoxathion, ivermectin, izopamfos, japonilure, japothrins, jasmolin I, jasmolin II, jasmonic acid, jiahuangchongzong, jiajizengxiaolin, jiaxiangjunzhi, jiecaowan, jiecaoxi, jodfenphos, juvenile hormone I, juvenile hormone II, juvenile hormone III, kadethrin, karbutilate, karetazan, karetazan-potassium, kasugamycin, kasugamycin hydrochloride, kejunlin, kelevan, ketospiradox, ketospiradox-potassium, kinetin, kinoprene, kresoxim-methyl, kuicaoxi, lactofen, lambda-cyhalothrin, latilure, lead arsenate, lenacil, lepimectin, leptophos, lindane, lineatin, linuron, lirimfos, litlure, looplure, lufenuron, lvdingjunzhi, lvxiancaolin, lythidathion, MAA, malathion, maleic hydrazide, malonoben, maltodextrin, MAMA, mancopper, mancozeb, mandipropamid, maneb, matrine, mazidox, MCPA, MCPA-2-ethylhexyl, MCPA-butotyl, MCPA-butyl, MCPA-dimethylammonium, MCPA-diolamine, MCPA-ethyl, MCPA-isobutyl, MCPA-isoctyl, MCPA-isopropyl, MCPA-methyl, MCPA-olamine, MCPA-potassium, MCPA-sodium, MCPA-thioethyl, MCPA-trolamine, MCPB, MCPB-ethyl, MCPB-methyl, MCPB-sodium, mebenil, mecarbam, mecarbinzid, mecarphon, mecoprop, mecoprop-2-ethylhexyl, mecoprop-dimethylammonium, mecoprop-diolamine, mecoprop-ethadyl, mecoprop-isoctyl, mecoprop-methyl, mecoprop-P, mecoprop-P-2-ethylhexyl, mecoprop-P-dimethylammonium, mecoprop-P-isobutyl, mecoprop-potassium, mecoprop-P-potassium, mecoprop-sodium, mecoprop-trolamine, medimeform, medinoterb, medinoterb acetate, medlure, mefenacet, mefenpyr, mefenpyr-diethyl, mefluidide, mefluidide-diolamine, mefluidide-potassium, megatomoic acid, menazon, mepanipyrim, meperfluthrin, mephenate, mephosfolan, mepiquat, mepiquat chloride, mepiquat pentaborate, mepronil, meptyldinocap, mercuric chloride, mercuric oxide, mercurous chloride, merphos, mesoprazine, mesosulfuron, mesosulfuron-methyl, mesotrione, mesulfen, mesulfenfos, metaflumizone, metalaxyl, metalaxyl-M, metaldehyde, metam, metam-ammonium, metamifop, metamitron, metam-potassium, metam-sodium, metazachlor, metazosulfuron, metazoxolon, metconazole, metepa, metflurazon, methabenzthiazuron, methacrifos, methalpropalin, methamidophos, methasulfocarb, methazole, methfuroxam, methidathion, methiobencarb, methiocarb, methiopyrisulfuron, methiotepa, methiozolin, methiuron, methocrotophos, methometon, methomyl, methoprene, methoprotryne, methoquin-butyl, methothrin, methoxychlor, methoxyfenozide, methoxyphenone, methyl apholate, methyl bromide, methyl eugenol, methyl iodide, methyl isothiocyanate, methylacetophos, methylchloroform, methyldymron, methylene chloride, methylmercury benzoate, methylmercury dicyandiamide, methylmercury pentachlorophenoxide, methylneodecanamide, metiram, metobenzuron, metobromuron, metofluthrin, metolachlor, metolcarb, metominostrobin, metosulam, metoxadiazone, metoxuron, metrafenone, metribuzin, metsulfovax, metsulfuron, metsulfuron-methyl, mevinphos, mexacarbate, mieshuan, milbemectin, milbemycin oxime, milneb, mipafox, mirex, MNAF, moguchun, molinate, molosultap, monalide, monisouron, monochloroacetic acid, monocrotophos, monolinuron, monosulfuron, monosulfuron-ester, monuron, monuron TCA, morfamquat, morfamquat dichloride, moroxydine, moroxydine hydrochloride, morphothion, morzid, moxidectin, MSMA, muscalure, myclobutanil, myclozolin, N-(ethylmercury)-p-toluenesulphonanilide, nabam, naftalofos, naled, naphthalene, naphthaleneacetamide, naphthalic anhydride, naphthoxyacetic acids, naproanilide, napropamide, naptalam, naptalam-sodium, natamycin, neburon, niclosamide, niclosamide-olamine, nicosulfuron, nicotine, nifluridide, nipyraclofen, nitenpyram, nithiazine, nitralin, nitrapyrin, nitrilacarb, nitrofen, nitrofluorfen, nitrostyrene, nitrothal-isopropyl, norbormide, norflurazon, nornicotine, noruron, novaluron, noviflumuron, nuarimol, OCH, octachlorodipropyl ether, octhilinone, ofurace, omethoate, orbencarb, orfralure, ortho-dichlorobenzene, orthosulfamuron, oryctalure, orysastrobin, oryzalin, osthol, ostramone, oxabetrinil, oxadiargyl, oxadiazon, oxadixyl, oxamate, oxamyl, oxapyrazon, oxapyrazon-dimolamine, oxapyrazon-sodium, oxasulfuron, oxaziclomefone, oxine-copper, oxolinic acid, oxpoconazole, oxpoconazole fumarate, oxycarboxin, oxydemeton-methyl, oxydeprofos, oxydisulfoton, oxyfluorfen, oxymatrine, oxytetracycline, oxytetracycline hydrochloride, paclobutrazol, paichongding, para-dichlorobenzene, parafluron, paraquat, paraquat dichloride, paraquat dimetilsulfate, parathion, parathion-methyl, parinol, pebulate, pefurazoate, pelargonic acid, penconazole, pencycuron, pendimethalin, penflufen, penfluron, penoxsulam, pentachlorophenol, pentanochlor, penthiopyrad, pentmethrin, pentoxazone, perfluidone, permethrin, pethoxamid, phenamacril, phenazine oxide, phenisopham, phenkapton, phenmedipham, phenmedipham-ethyl, phenobenzuron, phenothrin, phenproxide, phenthoate, phenylmercuriurea, phenylmercury acetate, phenylmercury chloride, phenylmercury derivative of pyrocatechol, phenylmercury nitrate, phenylmercury salicylate, phorate, phosacetim, phosalone, phosdiphen, phosfolan, phosfolan-methyl, phosglycin, phosmet, phosnichlor, phosphamidon, phosphine, phosphocarb, phosphorus, phostin, phoxim, phoxim-methyl, phthalide, picloram, picloram-2-ethylhexyl, picloram-isoctyl, picloram-methyl, picloram-olamine, picloram-potassium, picloram-triethylammonium, picloram-tris(2-hydroxypropyl)ammonium, picolinafen, picoxystrobin, pindone, pindone-sodium, pinoxaden, piperalin, piperonyl butoxide, piperonyl cyclonene, piperophos, piproctanyl, piproctanyl bromide, piprotal, pirimetaphos, pirimicarb, pirimioxyphos, pirimiphos-ethyl, pirimiphos-methyl, plifenate, polycarbamate, polyoxins, polyoxorim, polyoxorim-zinc, polythialan, potassium arsenite, potassium azide, potassium cyanate, potassium gibberellate, potassium naphthenate, potassium polysulfide, potassium thiocyanate, potassium -naphthaleneacetate, pp-DDT, prallethrin, precocene I, precocene II, precocene III, pretilachlor, primidophos, primisulfuron, primisulfuron-methyl, probenazole, prochloraz, prochloraz-manganese, proclonol, procyazine, procymidone, prodiamine, profenofos, profluazol, profluralin, profluthrin, profoxydim, proglinazine, proglinazine-ethyl, prohexadione, prohexadione-calcium, prohydrojasmon, promacyl, promecarb, prometon, prometryn, promurit, propachlor, propamidine, propamidine dihydrochloride, propamocarb, propamocarb hydrochloride, propanil, propaphos, propaquizafop, propargite, proparthrin, propazine, propetamphos, propham, propiconazole, propineb, propisochlor, propoxur, propoxycarbazone, propoxycarbazone-sodium, propyl isome, propyrisulfuron, propyzamide, proquinazid, prosuler, prosulfalin, prosulfocarb, prosulfuron, prothidathion, prothiocarb, prothiocarb hydrochloride, prothioconazole, prothiofos, prothoate, protrifenbute, proxan, proxan-sodium, prynachlor, pydanon, pymetrozine, pyracarbolid, pyraclofos, pyraclonil, pyraclostrobin, pyraflufen, pyraflufen-ethyl, pyrafluprole, pyramat, pyrametostrobin, pyraoxystrobin, pyrasulfotole, pyrazolynate, pyrazophos, pyrazosulfuron, pyrazosulfuron-ethyl, pyrazothion, pyrazoxyfen, pyresmethrin, pyrethrin I, pyrethrin II, pyrethrins, pyribambenz-isopropyl, pyribambenz-propyl, pyribencarb, pyribenzoxim, pyributicarb, pyriclor, pyridaben, pyridafol, pyridalyl, pyridaphenthion, pyridate, pyridinitril, pyrifenox, pyrifluquinazon, pyriftalid, pyrimethanil, pyrimidifen, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrimitate, pyrinuron, pyriofenone, pyriprole, pyripropanol, pyriproxyfen, pyrithiobac, pyrithiobac-sodium, pyrolan, pyroquilon, pyroxasulfone, pyroxsulam, pyroxychlor, pyroxyfur, quassia, quinacetol, quinacetol sulfate, quinalphos, quinalphos-methyl, quinazamid, quinclorac, quinconazole, quinmerac, quinoclamine, quinonamid, quinothion, quinoxyfen, quintiofos, quintozene, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, quwenzhi, quyingding, rabenzazole, rafoxanide, rebemide, resmethrin, rhodethanil, rhodojaponin-III, ribavirin, rimsulfuron, rotenone, ryania, saflufenacil, saijunmao, saisentong, salicylanilide, sanguinarine, santonin, schradan, scilliroside, sebuthylazine, secbumeton, sedaxane, selamectin, semiamitraz, semiamitraz chloride, sesamex, sesamolin, sethoxydim, shuangjiaancaolin, siduron, siglure, silafluofen, silatrane, silica gel, silthiofam, simazine, simeconazole, simeton, simetryn, sintofen, SMA, S-metolachlor, sodium arsenite, sodium azide, sodium chlorate, sodium fluoride, sodium fluoroacetate, sodium hexafluorosilicate, sodium naphthenate, sodium orthophenylphenoxide, sodium pentachlorophenoxide, sodium polysulfide, sodium thiocyanate, sodium -naphthaleneacetate, sophamide, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, spiroxamine, streptomycin, streptomycin sesquisulfate, strychnine, sulcatol, sulcofuron, sulcofuron-sodium, sulcotrione, sulfallate, sulfentrazone, sulfiram, sulfluramid, sulfometuron, sulfometuron-methyl, sulfosulfuron, sulfotep, sulfoxaflor, sulfoxide, sulfoxime, sulfur, sulfuric acid, sulfuryl fluoride, sulglycapin, sulprofos, sultropen, swep, tau-fluvalinate, tavron, tazimcarb, TCA, TCA-ammonium, TCA-calcium, TCA-ethadyl, TCA-magnesium, TCA-sodium, TDE, tebuconazole, tebufenozide, tebufenpyrad, tebufloquin, tebupirimfos, tebutam, tebuthiuron, tecloftalam, tecnazene, tecoram, teflubenzuron, tefluthrin, tefuryltrione, tembotrione, temephos, tepa, TEPP, tepraloxydim, terallethrin, terbacil, terbucarb, terbuchlor, terbufos, terbumeton, terbuthylazine, terbutryn, tetcyclacis, tetrachloroethane, tetrachlorvinphos, tetraconazole, tetradifon, tetrafluron, tetramethrin, tetramethylfluthrin, tetramine, tetranactin, tetrasul, thallium sulfate, thenylchlor, theta-cypermethrin, thiabendazole, thiacloprid, thiadifluor, thiamethoxam, thiapronil, thiazafluron, thiazopyr, thicrofos, thicyofen, thidiazimin, thidiazuron, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thifluzamide, thiobencarb, thiocarboxime, thiochlorfenphim, thiocyclam, thiocyclam hydrochloride, thiocyclam oxalate, thiodiazole-copper, thiodicarb, thiofanox, thiofluoximate, thiohempa, thiomersal, thiometon, thionazin, thiophanate, thiophanate-methyl, thioquinox, thiosemicarbazide, thiosultap, thiosultap-diammonium, thiosultap-disodium, thiosultap-monosodium, thiotepa, thiram, thuringiensin, tiadinil, tiaojiean, tiocarbazil, tioclorim, tioxymid, tirpate, tolclofos-methyl, tolfenpyrad, tolylfluanid, tolylmercury acetate, topramezone, tralkoxydim, tralocythrin, tralomethrin, tralopyril, transfluthrin, transpermethrin, tretamine, triacontanol, triadimefon, triadimenol, triafamone, tri-allate, triamiphos, triapenthenol, triarathene, triarimol, triasulfuron, triazamate, triazbutil, triaziflam, triazophos, triazoxide, tribenuron, tribenuron-methyl, tribufos, tributyltin oxide, tricamba, trichlamide, trichlorfon, trichlormetaphos-3, trichloronat, triclopyr, triclopyr-butotyl, triclopyr-ethyl, triclopyr-triethylammonium, tricyclazole, tridemorph, tridiphane, trietazine, trifenmorph, trifenofos, trifloxystrobin, trifloxysulfuron, trifloxysulfuron-sodium, triflumizole, triflumuron, trifluralin, triflusulfuron, triflusulfuron-methyl, trifop, trifop-methyl, trifopsime, triforine, trihydroxytriazine, trimedlure, trimethacarb, trimeturon, trinexapac, trinexapac-ethyl, triprene, tripropindan, triptolide, tritac, triticonazole, tritosulfuron, trunc-call, uniconazole, uniconazole-P, urbacide, uredepa, valerate, validamycin, valifenalate, valone, vamidothion, vangard, vaniliprole, vernolate, vinclozolin, warfarin, warfarin-potassium, warfarin-sodium, xiaochongliulin, xinjunan, xiwojunan, XMC, xylachlor, xylenols, xylylcarb, yishijing, zarilamid, zeatin, zengxiaoan, zeta-cypermethrin, zinc naphthenate, zinc phosphide, zinc thiazole, zineb, ziram, zolaprofos, zoxamide, zuomihuanglong, -chlorohydrin, -ecdysone, -multistriatin, and -naphthaleneacetic acid.
14. The composition of claim 1, further comprising an agriculturally acceptable carrier.
15. The composition of claim 1, wherein the compound is in the form of a pesticidally acceptable acid addition salt.
16. The composition of claim 1, wherein the compound is in the form of a salt derivative.
17. The composition of claim 1, wherein the compound is in the form a hydrate.
18. The composition of claim 1, wherein the compound is a resolved stereoisomer.
19. The composition of claim 1, wherein the compound is in the form a crystal polymorph.
20. The composition of claim 1, wherein the compound comprises a .sup.2H in place of .sup.1H.
21. The composition of claim 1, wherein the compound comprises a .sup.13C in place of a .sup.12C.
22. The composition of claim 1, further comprising a biopesticide.
23. The composition of claim 1, further comprising at least one of the following compounds: (a) 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-oxa-1-zaspiro[4,5]dec-3-en-2-one; (b) 3-(4-chloro-2,4-dimethyl[1,1-biphenyl]-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4,5]dec-3-en-2-one; (c) 4-[[(6-chloro-3-pyridinyl)methyl]methylamino]-2(5H)-furanone; (d) 4-[[(6-chloro-3-pyridinyl)methyl]cyclopropylamino]-2(5H)-furanone; (e) 3-chloro-N2-[(1S)-1-methyl-2-(methylsulfonyl)ethyl]-N1-[2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethypethyl]phenyl]-1,2-benzenedicarboxamide; (f) 2-cyano-N-ethyl-4-fluoro-3-methoxy-benenesulfonamide; (g) 2-cyano-N-ethyl-3-methoxy-benzenesulfonamide; (h) 2-cyano-3-difluoromethoxy-N-ethyl-4-fluoro-benzenesulfonamide; (i) 2-cyano-3-fluoromethoxy-N-ethyl-benzenesulfonamide; (j) 2-cyano-6-fluoro-3-methoxy-N,N-dimethyl-benzenesulfonamide; (k) 2-cyano-N-ethyl-6-fluoro-3-methoxy-N-methyl-benzenesulfonamide; (l) 2-cyano-3-difluoromethoxy-N,N-dimethylbenzenesulfon-amide; (m) 3-(difluoromethyl)-N-[2-(3,3-dimethylbutyl)phenyl]-1-methyl-1H-pyrazole-4-carboxamide; (n) N-ethyl-2,2-dimethylpropionamide-2-(2,6-dichloro-,,-trifluoro-p-tolyl)hydrazone; (o) N-ethyl-2,2-dichloro-1-methylcyclopropane-carboxamide-2-(2,6-dichloro-,,-trifluoro-p-tolyl)hydrazone nicotine; (p) O-{(E-)-[2-(4-chloro-phenyl)-2-cyano-1-(2-trifluoromethylphenyl)-vinyl]}S-methyl thiocarbonate; (q) (E)-N1-[(2-chloro-1,3-thiazol-5-ylmethyl)]-N2-cyano-N1-methylacetamidine; (r) 1-(6-chloropyridin-3-ylmethyl)-7-methyl-8-nitro-1,2,3,5,6,7-hexahydro-imidazo[1,2-a]pyridin-5-ol; (s) 4-[4-chlorophenyl-(2-butylidine-hydrazono)methyl)]phenyl mesylate; and (t) N-ethyl-2,2-dichloro-1-methylcyclopropanecarboxamide-2-(2,6-dichloro-,,-trifluoro-p-tolyl)hydrazone.
24. The composition of claim 1, further comprising a compound having one or more of the following modes of action: acetylcholinesterase inhibitor; sodium channel modulator; chitin biosynthesis inhibitor; GABA and glutamate-gated chloride channel antagonist; GABA and glutamate-gated chloride channel agonist; acetylcholine receptor agonist; acetylcholine receptor antagonist; MET I inhibitor; Mg-stimulated ATPase inhibitor; nicotinic acetylcholine receptor; Midgut membrane disrupter; oxidative phosphorylation disrupter, and ryanodine receptor (RyRs).
25. The composition of claim 1, further comprising a seed.
26. The composition of claim 1, further comprising a seed that has been genetically modified to express one or more specialized traits.
27. The composition of to claim 1, wherein the composition is encapsulated inside, or placed on the surface of, a capsule.
28. The composition of claim 1, wherein the composition is encapsulated inside, or placed on the surface of, a capsule, wherein the capsule has a diameter of about 100-900 nanometers or about 10-900 microns.
29. A process comprising applying a composition of claim 1, to an area to control a pest, in an amount sufficient to control such pest.
30. The process of claim 29, wherein the pest is selected from beetles, earwigs, cockroaches, flies, aphids, scales, whiteflies, leafhoppers, ants, wasps, termites, moths, butterflies, lice, grasshoppers, locusts, crickets, fleas, thrips, bristletails, mites, ticks, nematodes, and symphylans.
31. The process of claim 29, wherein the pest is from the Phyla Nematoda or Arthropoda.
32. The process of claim 29, wherein the pest is from the Subphyla Chelicerata, Myriapoda, or Hexapoda.
33. The process of claim 29, wherein the pest is from the Class of Arachnida, Symphyla, or Insecta.
34. The process of claim 29, wherein the pest is from the Order Anoplura, Order Coleoptera, Order Dermaptera, Order Blattaria, Order Diptera, Order Hemiptera, Order Hymenoptera, Order Isoptera, Order Lepidoptera, Order Mallophaga, Order Orthoptera, Order Siphonaptera, Order Thysanoptera, Order Thysanura, Order Acarina, or Order Symphyla.
35. The process of claim 29, wherein the pest is MYZUPE or BEMITA.
36. The process of claim 29, wherein an amount of the composition is from about 0.01 grams per hectare to about 5000 grams per hectare.
37. The process of claim 29, wherein an amount of the composition is from about 0.1 grams per hectare to about 500 grams per hectare.
38. The process of claim 29, wherein an amount of the composition is from about 1 gram per hectare to about 50 grams per hectare.
39. The process of claim 29, wherein the area is an area where apples, corn, cotton, soybeans, canola, wheat, rice, sorghum, barley, oats, potatoes, oranges, alfalfa, lettuce, strawberries, tomatoes, peppers, crucifers, pears, tobacco, almonds, sugar beets, or beans, are growing, or the seeds thereof are going to be planted.
40. The process of claim 29, further comprising applying the composition to a genetically modified plant that has been genetically modified to express one or more specialized traits.
41. The process of claim 29, where the composition further comprises ammonium sulfate.
42. A method of preparing the 1-(3-pyridyl-N-oxide)pyrazole compound of claim 1, the method comprising: ##STR00269## oxidizing a 1-(3-pyridyl)pyrazole compound of formula 1-1 to provide the 1-(3-pyridyl-N-oxide)pyrazole compound of formula 1-2, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.10, Q, and n are defined as in claim 1.
43. A method of preparing the 1-(3-pyridyl-N-oxide)pyrazole compound of claim 1, the method comprising: ##STR00270## reacting the 1-(3-pyridyl-N-oxide)pyrazole compound 2-3 with a carboxyl compound of formula 3-1 where R.sub.12 is OH or Cl, to provide 1-(3-pyridyl-N-oxide)pyrazole-4-amide compound of formula 3-2.
44. The method of claim 43, further comprising: treating the 1-(3-pyridyl-N-oxide)pyrazole-4-amide compound of formula 3-2 with a thionating agent to provide 1-(3-pyridyl-N-oxide)pyrazole-4-thioamide compound of formula 4-1 ##STR00271##
45. A method of preparing the 1-(3-pyridyl-N-oxide)pyrazole compound of claim 1, the method comprising: ##STR00272## oxidizing a 1-(3-pyridyl-N-oxide)pyrazole sulfide of formula 5-1 to provide a 1-(3-pyridyl-N-oxide)pyrazole compound of formula 5-2, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.9, R.sub.10, Q, and n are defined as in claim 1.
Description
DETAILED DESCRIPTION
(1) Insecticidal Testing
Example A
Bioassay for Green Peach Aphid (Myzus persicae) (GPA) (MYZUPE)
(2) The green peach aphid (Myzus persicae) is the most significant aphid pest of peach trees, causing decreased growth, shriveling of the leaves, and the death of various tissues. It is also hazardous because it acts as a vector for the transport of plant viruses, such as potato virus Y and potato leafroll virus to members of the nightshade/potato family Solanaceae, and various mosaic viruses to many other food crops. GPA attacks such plants as broccoli, burdock, cabbage, carrot, cauliflower, daikon, eggplant, green beans, lettuce, macadamia, papaya, peppers, sweet potatoes, tomatoes, watercress, and zucchini, among other plants. GPA also attacks many ornamental crops such as carnation, chrysanthemum, flowering white cabbage, poinsettia, and roses. GPA has developed resistance to many pesticides.
(3) Cabbage seedlings grown in 3-inch pots, with 2-3 small (3-5 cm) true leaves, were used as test substrate. The seedlings were infested with 20-50 GPA (wingless adult and nymph stages) one day prior to chemical application. Four pots with individual seedlings were used for each treatment. Test compounds (2 mg) were dissolved in 2 mL of acetone/methanol (1:1) solvent, forming stock solutions of 1000 ppm test compound. The stock solutions were diluted 5 with 0.025% Tween 20 in H.sub.2O to obtain the solution at 200 ppm test compound. A hand-held aspirator-type sprayer was used for spraying a solution to both sides of cabbage leaves until runoff. Reference plants (solvent check) were sprayed with the diluent only containing 20% by volume of acetone/methanol (1:1) solvent. Treated plants were held in a holding room for three days at approximately 25 C. and ambient relative humidity (RH) prior to grading. Evaluation was conducted by counting the number of live aphids per plant under a microscope. Percent control was measured by using Abbott's correction formula (W. S. Abbott, A Method of Computing the Effectiveness of an Insecticide, J. Econ. Entomol. 18 (1925), pp. 265-267) as follows.
Corrected % Control=100*(XY)/X
(4) where
(5) X=No. of live aphids on solvent check plants and
(6) Y=No. of live aphids on treated plants
(7) The results are indicated in the table entitled TABLE 2. Biological Data for Green Peach Aphid (GPA) (MYZUPE) and Sweetpotato Whitefly-crawler (WF) (BEMITA) (See Table Section).
Example B
Insecticidal Test for Sweetpotato Whitefly-Crawler (WF) (Bemisia tabaci) (BEMITA) in Foliar Spray Assay
(8) The sweetpotato whitefly (Bemisia tabaci) has been reported as a serious pest of cultivated crops world-wide. It has an extremely wide host range attacking more than 500 species of plants from 63 plant families. Weeds often serve as alternate hosts of crop pests. Direct feeding damage is caused by the piercing and sucking sap from the foliage of plants. This feeding causes weakening and early wilting of the plant and reduces the plant growth rate and yield. Indirect damage results by the accumulation of honeydew produced by the whiteflies. Honeydew serves as a substrate for the growth of black sooty mold on leaves and fruit reducing photosynthesis and lessens the market value of the plant or yield. Damage is also caused when sweetpotato whitefly vectors plant viruses. The sweetpotato whitefly is considered the most common and important whitefly vector of plant viruses worldwide.
(9) Cotton plants (Gossypium hirsutum) grown in 3-inch pots, with 1 small (4-5 cm) true leaves, were used as test substrate. The plants were infested with 200-400 whitefly eggs 4-5 days prior to chemical application. Four pots with individual plants were used for each treatment. Test compounds (2 mg) were dissolved in 1 mL of acetone solvent, forming stock solutions of 2000 ppm test compound. The stock solutions were diluted 10 with 0.025% Tween 20 in H.sub.2O (diluents) to obtain the solution at 200 ppm test compound. A hand-held aspirator-type sprayer was used for spraying a solution to both sides of cotton leaves until runoff. Reference plants (solvent check) were sprayed with the diluent only containing 10% by volume of acetone solvent. Treated plants were held in a holding room for 9 days at approximately 25 C. and ambient relative humidity (RH) prior to grading. Evaluation was conducted by counting the number of live 3-4 nymph stage per plant under a microscope. Percent control was measured by using Abbott's correction formula (W. S. Abbott, A Method of Computing the Effectiveness of an Insecticide, J. Econ. Entomol. 18 (1925), pp. 265-267) as follows.
Corrected % Control=100*(XY)/X
(10) where
(11) X=No. of live nymphs on solvent check plants and
(12) Y=No. of live nymphs on treated plants.
(13) The results are indicated in the table entitled TABLE 2. Biological Data for Green Peach Aphid (GPA) (MYZUPE) and Sweetpotato Whitefly-crawler (WF) (BEMITA) (See Table Section).
(14) The mortality efficiency of the disclosed pesticidal compounds against GPA and WF insects was rated as shown in TABLE 1.
(15) TABLE-US-00001 TABLE 1 % Control (or Mortality) Rating 80-100 A More than 0 - Less than 80 B Not Tested C No activity noticed in this bioassay D
(16) TABLE-US-00002 TABLE 2 Biological Data for GPA (MYZUPE) and WF-crawler (BEMITA) Insect Species GPA WF No. 200 ppm 200 ppm F1 A A F2 A A F4 A A F5 A A F6 A A F7 A B F8 A A F9 A A F10 A A F11 A A F12 A A F13 A A C1 B B P1 A A P2 A A P9 A A P10 A A P18 A A P19 A A P36 A A P37 A A P48 A A P49 A A P50 A A P53 A A P54 A A P56 A A P57 A A P62 A A P63 A A P65 A A P66 A A P71 A A P72 A A P74 A A P75 A A P80 A A P81 A A P92 A A P93 A A P98 B A P99 A A FA1 A A FA2 A A FA3 A A FA4 A A FA5 A A FA6 A A FA7 A A FA8 A A FA9 A A FA10 A B FA11 A B FA12 A A FA13 A C FA14 A C CA1 B B CA2 B A CA3 A B CA4 B B
EXAMPLES
(17) These examples are for illustration purposes and are not to be construed as limiting the disclosure to only the embodiments disclosed in these examples.
(18) Starting materials, reagents, and solvents that were obtained from commercial sources were used without further purification. Anhydrous solvents were purchased as SURE/SEAL from Aldrich and were used as received. Melting points were obtained on a Thomas Hoover Unimelt capillary melting point apparatus or an OptiMelt Automated Melting Point System from Stanford Research Systems and are uncorrected. Examples using room temperature were conducted in climate controlled laboratories with a temperature of from about 20 C. to about 24 C. Molecules are given their known names, named according to naming programs within ISIS Draw, ChemDraw or ACD Name Pro. If such programs are unable to name a molecule, the molecule is named using conventional naming rules. .sup.1H NMR spectral data are in ppm () and were recorded at 300, 400 or 600 MHz. .sup.13C NMR spectral data are in ppm () and were recorded at 75, 100 or 150 MHz. .sup.19F NMR spectral data are in ppm () and were recorded at 376 MHz, unless otherwise stated.
Example 1
Preparation of 3-(3-chloro-4-(ethylamino)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound C1
(19) ##STR00010##
(20) To a solution of 3-(4-((tert-butoxycarbonyl)(ethyl)amino)-3-chloro-1H-pyrazol-1-yl)pyridine 1-oxide (prepared as described in the PCT Publication No. WO 2012/108511) (0.459 g, 1.36 mmol) in CH.sub.2Cl.sub.2 (13.5 mL) at a temperature of about 0 C. was added TFA (1.04 mL, 13.6 mmol). The reaction was allowed to warm to room temperature and stirred for 18 hours. The reaction was diluted with toluene (10 mL) and concentrated to dryness under reduced pressure. The residue was taken up in CH.sub.2Cl.sub.2 (100 mL) and washed with saturated aqueous sodium bicarbonate (NaHCO.sub.3, 100 mL). The layers were separated, and the organic phases were dried over sodium sulfate (Na.sub.2SO.sub.4), filtered, and concentrated under reduced pressure to provide the title compound Cl as a tan solid (0.278 g, 85%): mp 148 C.-153 C.; .sup.1H NMR (400 MHz, CDCl.sub.3) 8.55 (t, J=1.8 Hz, 1H), 8.04 (ddd, J=6.4, 1.7, 0.9 Hz, 1H), 7.52 (ddd, J=8.5, 2.0, 0.9 Hz, 1H), 7.33-7.27 (m, 1H), 7.19 (s, 1H), 3.17-2.97 (m, 3H), 1.30 (t, J=6.8 Hz, 3H); ESIMS m/z 239 ([M+H].sup.+).
(21) The following molecules were made in accordance with the procedures disclosed in Example 1, supra:
(22) ##STR00011##
(23) 3-(3-Chloro-4-(prop-2-yn-1-ylamino)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound CA1) was isolated (4.0 g, 82%): mp 167-173 C.; .sup.1H NMR (400 MHz, CDCl.sub.3) 8.58 (d, J=2.0 Hz, 1H), 8.06 (d, J=6.4 Hz, 1H), 7.56 (dd, J=8.0, 1.6 Hz, 1H), 7.42 (s, 1H), 7.30 (dd, J=8.0, 6.4 Hz, 1H), 3.98 (d, J=2.4 Hz, 2H), 2.30 (t, J=2.4 Hz, 1H), NH not observed; ESIMS m/z 249 ([M+H].sup.+).
(24) ##STR00012##
(25) 3-(4-(Ethylamino)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound CA2) was isolated as a light brown solid (5.40 g, 87%): mp 105-108 C.; .sup.1H NMR (400 MHz, CDCl.sub.3) 8.58 (s, 1H), 7.98 (dd, J=8.4, 1.2 Hz, 1H), 7.52 (dd, J=8.4, 1.2 Hz, 1H), 7.25 (s, 1H), 7.22 (d, J=8.4 Hz, 1H), 3.06 (q, J=7.2 Hz, 2H), 2.23 (s, 3H), 1.30 (t, J=7.2 Hz, 3H), NH not observed; ESIMS m/z 219 ([M+H].sup.+).
(26) ##STR00013##
(27) 3-(3-Chloro-4-(methylamino)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound CA3) was isolated (2.5 g, 58%): mp 142-145 C.; .sup.1H NMR (400 MHz, CDCl.sub.3) 8.56 (d, J=1.6 Hz, 1H), 8.04 (d, J=6.4 Hz, 1H), 7.52 (dd, J=8.0, 1.6 Hz, 1H), 7.28 (dd, J=8.0, 6.4 Hz, 1H), 7.21 (s, 1H), 2.85 (s, 3H), NH not observed; ESIMS m/z 225 ([M+H].sup.+).
(28) ##STR00014##
(29) 3-(3-Chloro-4-(ethylamino)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound CA4) was isolated as an off-white solid (4.0 g, 100%): mp 134-146 C.; .sup.1H NMR (400 MHz, CDCl.sub.3) 8.39 (s, 1H), 7.96 (dd, J=3.6, 1.6 Hz, 1H), 7.36 (dd, J=3.6, 1.6 Hz, 1H), 7.14 (s, 1H), 3.60 (q, J=7.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H), NH not observed; ESIMS m/z 257 ([M+H].sup.+).
Example 2
Preparation of S-(1-((3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)(ethyl)amino)-1-oxopropan-2-yl)ethanethioate
Compound C3
(30) ##STR00015##
(31) To a solution of 2-chloro-N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylpropanamide (1.00 g, 3.19 mmol) in acetone (6.4 mL) was added potassium ethanethioate (0.438 g, 3.83 mmol). The reaction vessel was capped and heated at a temperature of about 60 C. for 1.5 hours. The reaction was cooled to room temperature and poured into a separatory funnel containing water (20 mL) and EtOAc (20 mL). The layers were separated, and aqueous layer was extracted with EtOAc (320 mL). The combined organic extract was dried over anhydrous Na.sub.2SO.sub.4, filtered, and concentrated under reduced pressure. The crude residue was purified via flash chromatography (SiO.sub.2) eluting with 20-100% EtOAc/hexanes to give the title molecule C3 as brown, highly viscous oil (1.07 g, 90%).
Example 3
Preparation of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-2-((2,2,2-trifluoroethyl)thio)propanamide
Compound C4
(32) ##STR00016##
(33) To a dry round-bottom flask under nitrogen were added sodium hydride (60% dispersion in oil, 0.018 g, 0.45 mmol) and tetrahydrofuran (THF, 2.1 mL), followed by MeOH (0.018 mL, 0.45 mmol). The reaction was allowed to stir at room temperature until cessation of hydrogen evolution was observed (45 min). The reaction was then cooled to a temperature of 0 C., and S-(1-((3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)(ethyl)amino)-1-oxopropan-2-yl) ethanethioate (0.150 g, 0.425 mmol) in THF (2.1 mL) was added. The reaction was warmed to room temperature and stirred for 30 minutes. The reaction was again cooled to a temperature of about 0 C., and 1,1,1-trifluoro-2-iodoethane (0.063 mL, 0.64 mmol) in THF (2.1 mL) was added. The reaction was warmed to room temperature and stirred overnight. The reaction was diluted in ethyl acetate (EtOAc, 20 mL) and quenched with water (5 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (310 mL). The combined organic extracts were dried over Na.sub.2SO.sub.4, filtered, and concentrated under reduced pressure to give yellow oil. The crude product was purified via flash chromatography (SiO.sub.2) eluting with 0%-75% EtOAc/CH.sub.2Cl.sub.2 to give the title molecule C4 as opaque, viscous oil (0.043 g, 25%). IR (thin film) 1657 cm.sup.1; .sup.1H NMR (400 MHz, CDCl.sub.3) 8.96 (d, J=2.6 Hz, 1H), 8.64 (dd, J=4.8, 1.4 Hz, 1H), 8.14-7.96 (m, 2H), 7.47 (dd, J=8.3, 4.8 Hz, 1H), 3.82 (s, 1H), 3.59 (s, 1H), 3.44 (s, 1H), 3.25 (qd, J=10.2, 3.8 Hz, 2H), 1.48 (d, J=6.8 Hz, 3H), 1.17 (t, J=7.2 Hz, 3H); .sup.19F NMR (376 MHz, CDCl.sub.3) 66.16; ESIMS m/z 393 ([M+H].sup.+).
Example 4
Preparation of 3-(4-(N-ethyl-2-methyl-3-(methylsulfonyl)propanamido)-3-methyl-1H-pyrazol-1-yl)pyridine-1-oxide
Compound F4
(34) ##STR00017##
(35) To a solution of N-ethyl-2-methyl-N-(3-methyl-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-3-(methylthio)propanamide (prepared as described in the PCT Publication No. WO 2013/062981) (0.12 g, 0.38 mmol) in AcOH (1 mL) was added sodium perborate tetrahydrate (0.13 g, 0.83 mmol) and heated at a temperature of about 60 C. for one hour. The reaction was quenched with saturated aqueous NaHCO.sub.3, extracted with EtOAc, and concentrated under reduced pressure. Purification by flash chromatography (SiO.sub.2) eluting with 0%-15% MeOH/CH.sub.2Cl.sub.2 afforded the title compound F4 as clear oil (0.014 g, 10%).
(36) The following molecules were made in accordance with the procedures disclosed in Example 4:
(37) ##STR00018##
(38) 3-(3-Chloro-4-(N-ethyl-2-methyl-3-(methylsulfonyl)propanamido)-1H-pyrazol-1-yl) 1-oxide (Compound F12) was obtained from N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-2-methyl-3-(methylthio)propanamide (prepared as described in the U.S. Publication No. 2012/0110702) and isolated as clear oil (0.009 g, 10%).
(39) ##STR00019##
(40) 3-(3-Chloro-4-(N-ethyl-2-((2,2,2-trifluoroethyl)sulfonyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound F8) was isolated as a white solid (0.0099 g, 8%).
(41) ##STR00020##
(42) 3-(3-Chloro-4-(N-ethyl-2-((2,2,2-trifluoroethyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound F7) was isolated as a white solid (0.0104 g, 9%).
(43) ##STR00021##
(44) 3-(3-chloro-4-(N-ethyl-2-(methylsulfonyl)acetamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA11) was isolated as a white semi-solid (0.077 g, 25%).
(45) ##STR00022##
(46) 3-(3-chloro-4-(N-methyl-2-(methylsulfonyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FAl2) was isolated as a off-white semi-slid (0.1 g, 27%).
(47) ##STR00023##
(48) 3-(3-chloro-4-(N-ethyl-2-(methylsulfonyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA13) was isolated as a white semi-solid (0.092 g, 15%).
(49) ##STR00024##
(50) 3-(3-chloro-4-(N-(cyclopropylmethyl)-2-(methylsulfonyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA14) was isolated as a yellow semi-solid (0.096 g, 16%).
Example 5
Preparation of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-3-mercatopropanamide
Compound C6
(51) ##STR00025##
(52) To a solution of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-3-(tritylthio)propanamide (0.169 g, 0.306 mmol) in CH.sub.2Cl.sub.2 (3 mL) were added triethylsilane (0.244 mL, 1.53 mmol) and TFA (0.235 mL, 3.06 mmol), sequentially. The reaction was stirred overnight at room temperature. The reaction mixture was diluted with CH.sub.2Cl.sub.2 (10 mL) and carefully poured into a separatory funnel containing saturated aqueous NaHCO.sub.3 (10 mL). The layers were mixed and then separated. The aqueous phase was extracted with CH.sub.2Cl.sub.2 (310 mL), and the combined organic extracts were dried over Na.sub.2SO.sub.4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (SiO.sub.2) eluting with 0%-100% EtOAc/CH.sub.2Cl.sub.2 afforded the title compound C6 as a white solid (0.086 g, 86%). .sup.1H NMR (400 MHz, CDCl.sub.3) 8.96 (dd, J=2.7, 0.7 Hz, 1H), 8.63 (dd, J=4.8, 1.5 Hz, 1H), 8.06 (ddd, J=8.3, 2.7, 1.5 Hz, 1H), 7.97 (s, 1H), 7.47 (ddd, J=8.4, 4.8, 0.8 Hz, 1H), 3.72 (1, J=7.2 Hz, 2H), 2.79 (dt, J=8.4, 6.7 Hz, 2H), 2.49 (t, J=6.7 Hz, 2H), 1.67 (t, J=8.4 Hz, 1H), 1.17 (t, J=7.2 Hz, 3H); ESIMS m/z 311 ([M+H].sup.+).
Example 6
Preparation of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-3-(((2,2-difluorocyclopropyl)methyl)thio)-N-ethylpropanamide
Compound C7
(53) ##STR00026##
(54) To a solution of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-3-mercatopropanamide (0.10 g, 0.32 mmol) in THF (1 mL) was added sodium hydride (60% dispersion in oil, 0.014 g, 0.34 mmol). The resulting mixture was stirred at room temperature for 10 minutes, followed by addition of 2-(bromomethyl)-1,1-difluorocyclopropane (0.060 g, 0.35 mmol). The mixture was stirred at room temperature for 24 hours and diluted with saturated aqueous ammonium chloride (NH.sub.4Cl) and EtOAc. The organic phase was separated, and the aqueous phase extracted with EtOAc (250 mL). The combined organic extracts were dried over magnesium sulfate (MgSO.sub.4), filtered, and concentrated under reduced pressure to give colorless oil. This oil was purified by flash chromatography (SiO.sub.2) eluting with a mixture of EtOAc and hexanes to give the title molecule C7 as a colorless gum (0.10 g, 78%). IR (thin film) 3092, 2975, 2931, 1659, 1584 cm.sup.1; .sup.1H NMR (400 MHz, CDCl.sub.3) 8.99-8.90 (m, 1H), 8.63 (dd, J=4.8, 1.5 Hz, 1H), 8.05 (ddd, J=8.3, 2.7, 1.5 Hz, 1H), 7.96 (s, 1H), 7.47 (ddd, J=8.3, 4.7, 0.7 Hz, 1H), 3.72 (q, J=7.2 Hz, 2H), 2.87 (t, J=7.3 Hz, 2H), 2.63-2.55 (m, 2H), 2.46 (t, J=7.3 Hz, 2H), 1.76 (ddq, J=13.2, 11.4, 7.5 Hz, 1H), 1.48 (dddd, J=12.3, 11.2, 7.8, 4.5 Hz, 1H), 1.17 (t, J=7.2 Hz, 3H), 1.04 (dtd, J=13.2, 7.6, 3.7 Hz, 1H); ESIMS m/z 400 ([M+H].sup.+).
Example 7
Preparation of 3(3-chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)sulfonyl-N-ethylpropanamide)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound F11
(55) ##STR00027##
(56) To a solution of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-3-(((2,2-difluorocyclopropyl)methyl)thio)-N-ethylpropanamide (0.177 g, 0.422 mmol) in CH.sub.2Cl.sub.2 (5 mL) was added 3-chloroperoxybenzoic acid (m-CPBA, 77%, 0.435 g, 1.77 mmol) and stirred at room temperature for one hour. The reaction mixture was diluted with CH.sub.2Cl.sub.2 and washed with saturated aqueous NH.sub.4Cl and brine, dried over MgSO.sub.4, and concentrated under reduced pressure. Purification by flash chromatography (SiO.sub.2) eluting with CH.sub.2Cl.sub.2 and MeOH afforded the title compound F11 as an off-white solid (0.157 g, 79%).
(57) The following compounds in Table 5 may be prepared according to the procedures disclosed in Example 7:
(58) P3, P6, P11, P14, P17, P20, P23, P26, P29, P35, P38, P41, P44, P47, P52, P55, P58, P61, P64, P67, P70, P73, P76, P79, P82, P85, P88, P91, P94, P97, P100, P103, P106, P109.
Example 8
Preparation of 3-((3,3,3-trifluoropropyl)thio)propanoyl chloride
Compound C8
(59) ##STR00028##
(60) A dry 5-liter round bottom flask equipped with magnetic stirrer, nitrogen inlet, reflux condenser, and thermometer, was charged with 3-((3,3,3-trifluoropropyl)thio)propanoic acid (prepared as described in the PCT Publication No. WO 2012/062981) (188 g, 883 mmol) in CH.sub.2Cl.sub.2 (3 L). Thionyl chloride (525 g, 321 mL, 4.42 mol) was then added dropwise over 50 minutes. The reaction mixture was heated to reflux for two hours, then cooled to room temperature. Concentration under reduced pressure on a rotary evaporator, followed by distillation (40 Torr, product collected a temperature of from about 123 C. to about 127 C.) gave the title compound C8 as clear colorless liquid (177 g, 86%). .sup.1H NMR (400 MHz, CDCl.sub.3) 3.20 (t, J=7.1 Hz, 2H), 2.86 (t, J=7.1 Hz, 2H), 2.78-2.67 (m, 2H), 2.48-2.31 (m, 2H).
Example 9
Preparation of 3-(3-chloro-4-(N-ethyl-3-((3,3,3-trifluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound F5
(61) ##STR00029##
(62) To a solution of 3-(3-chloro-4-(ethylamino)-1H-pyrazol-1-yl)pyridine 1-oxide (0.23 g, 0.98 mmol) in CH.sub.2Cl.sub.2 (10 mL) at a temperature of about 0 C. were added DIPEA (0.26 mL, 1.5 mmol), DMAP (0.012 g, 0.098 mmol), and 3-((3,3,3-trifluoropropyl)thio)propanoyl chloride (0.24 g, 1.1 mmol) sequentially. The reaction was warmed to room temperature and stirred for 4 hours. The reaction was quenched with water (10 mL) and vigorously stirred for 5 minutes. The phases were separated, and the aqueous phase was extracted with CH.sub.2Cl.sub.2 (310 mL). The combined organic extracts were dried over Na.sub.2SO.sub.4, filtered and concentrated under reduced pressure. Purification by reverse phase flash chromatography eluting with 0%-100% acetonitrile (MeCN)/water afforded the title compound F5 as orange oil (0.197 g, 45%).
(63) The following molecules were made in accordance with the procedures disclosed in Example 9:
(64) ##STR00030##
(65) 3-(3-Chloro-4-(N-ethyl-2-methyl-3-(methylthio)propajamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound F10) was obtained from 2-methyl-3-(methylthio)propanoyl chloride (prepared as described in the U.S. Publication NO. 2012/0053146) and isolated as orange oil (0.299 g, 66%).
(66) ##STR00031##
(67) 3-(3-Chloro-4-(N-ethyl-3-(methylthio)propanamido)-1H-pyrazol-1-yl) pyridine 1-oxide (Compound F2) was obtained from 3-methylthiopropionyl chloride and isolated as a white solid (0.251 g, 53%).
(68) The following compounds in TABLE 5 may be prepared according to the procedures disclosed in Example 9:
(69) P1, P4, P7, P9, P12, P15, P18, P21, P24, P32, P36, P39, P42, P45, P48, P50, P53, P56, P59, P62, P65, P68, P71, P74, P77, P80, P92, P95, P98, P101, P104, P107
Example 10
Preparation of 3-(3-chloro-4-(N-ethyl-3-((3,3,3-trifluoropropyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound F1
(70) ##STR00032##
(71) To a solution of 3-(3-chloro-4-(N-ethyl-3-((3,3,3 trifluoropropyl)thio) propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (0.095 g, 0.225 mmol) in MeOH (1.1 mL) at room temperature was added a 30% aqueous solution of H.sub.2O.sub.2 (0.069 mL, 0.67 mmol). The reaction was stirred at room temperature overnight for 18 hours. The reaction was concentrated under reduced pressure, diluted with CH.sub.2Cl.sub.2 (1 mL) and MeOH (1 mL), and concentrated under reduced pressure. Purification by reverse phase flash chromatography eluting with 0%-100% MeCN/water afforded the title compound F1 as a white semi-solid (0.081 g, 78%).
(72) The following molecules were made in accordance with the procedures disclosed in Example 10:
(73) ##STR00033##
(74) 3-(3-Chloro-4-(N-ethyl-2-methyl-3-(methylsulfinyl)propanamido-1H-pyrazol-1-yl)pyridine 1-oxide (Compound F6) was isolated as a clear semi-solid (0.092 g, 84%).
(75) ##STR00034##
(76) 3-(3-Chloro-4-(N-ethyl-3-(methylsulfinyl)propanamido)-1H-pyrazol-1-yl) pyridine 1-oxide (Compound F9) was isolated as a clear semi-solid (0.093 g, 87%).
(77) The following compounds in Table 4 may be prepared according to the procedures disclosed in Example 10:
(78) P2, P5, P8, P10, P13, P16, P19, P22, P25, P28, P31, P34, P37, P40, P43, P46, P49, P51, P54, P57, P60, P63, P66, P72, P75, P78, P81, P84, P87, P90, P93, P96, P99, P102, P105, P108.
Example 11
Preparation of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-3-((3,3,3-trifluoropropyl)thio)propanamide
Compound C9
(79) ##STR00035##
(80) To a solution of 3-chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-4-amine (prepared as described in the PCT Publication No. WO 2013/062981) (10 g, 44.9 mmol) in CH.sub.2Cl.sub.2 (100 mL) at a temperature of about 0 C. and under N.sub.2 were added pyridine (5.45 mL, 67.4 mmol), 4-dimethylaminopyridine (DMAP) (2.74 g, 22.45 mmol), and 3-((3,3,3-trifluoropropyl)thio)propanoyl chloride (9.91 g, 44.9 mmol), sequentially. The reaction was warmed to ambient temperature and stirred for one hour. The reaction was poured into water (100 mL) and the resulting mixture was stirred for 5 min. The mixture was transferred to a separatory funnel and the layers were separated. The aqueous phase was extracted with CH.sub.2Cl.sub.2 (350 mL) and the combined organic extracts were dried over Na.sub.2SO.sub.4, filtered and concentrated in vacuo. The crude product was purified via normal phase flash chromatography (0 to 100% EtOAc/CH.sub.2Cl.sub.2) to afford the desired product as a pale yellow solid (17.21 g, 89%).
Example 12
Preparation of 3-(3-chloro-4-(N-ethyl-3-((3,3,3-trifluoropropyl)sulfonyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound F13
(81) ##STR00036##
(82) To a solution of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethyl-3-((3,3,3-trifluoropropyl)thio)propanamide (0.203 g, 0.499 mmol) in AcOH (5 mL) at room temperature was added sodium perborate, tetrahydrate (0.230 g, 1.50 mmol). The mixture was warmed to a temperature of 55 C. and stirred for 5 hours. The reaction was cooled to room temperature and carefully diluted with saturated aqueous NaHCO.sub.3 (5 mL) and EtOAc (10 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (310 mL). The combined organic extracts were washed with brine, dried over Na.sub.2SO.sub.4, filtered, and concentrated under reduced pressure. Purification by flash chromatography (SiO.sub.2) eluting with 0%-30% MeOH/EtOAc afforded the title compound F13 as a white solid (0.129 g, 54%).
Example 13
Prophetic preparation of 3-(3-chloro-4-(N-ethyl-3-((3,3,3trifluoropropyl)thio)propanethioamido)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound P27
(83) ##STR00037##
(84) To a solution of 3-(3-chloro-4-(N-ethyl-3-((3,3,3 trifluoropropyl)thio) propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (1 equivalent (eq)) in a solvent, such as toluene, (at a concentration between about 0.01 M to about 1 M) at ambient temperature may be added a thionating reagent, such as Lawesson's reagent (from about 0.5 eq to about 1 eq). The reaction may be capped in a microwave vial and heated at a temperature from about 100 C. to about 150 C. for from about 15 minutes to about 90 minutes in a BIOTAGE INITIATOR microwave reactor with external IR-sensor temperature monitoring from the side of the vessel. The product may be then obtained using standard organic chemistry techniques or workup and purification.
(85) The following compounds in TABLE 5 may be prepared according to the procedures disclosed in Example 13: P30, P33, P83, P86, P89.
Example 14
Preparation of 3-(3-chloro-4-(N-methyl-3-((3,3,3-trifluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound P1
(86) ##STR00038##
(87) A stirred suspension of 3-(3-chloro-4-(methylamino)-1H-pyrazol-1-yl)pyridine 1-oxide (0.15 g, 0.66 mmol) in THF (10 mL) was charged with DMAP (0.33 mmol) and 34(3,3,3-trifluoropropyl)thio)propanoyl chloride (0.32 g, 1.5 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was diluted with water (20 mL) and was extracted with EtOAc (225 mL). The combined organic layer was washed with a saturated NaHCO.sub.3 solution (220 mL) and brine (220 mL). The separated organic layer was dried over solid Na.sub.2SO.sub.4, filtered, and concentrated. The crude residue was purified by flash column chromatography using 0-10% MeOH/CH.sub.2Cl.sub.2 as eluent provide the title compound (0.20 g, 75%).
(88) The following molecules were made in accordance with the procedures disclosed in Example 14:
(89) ##STR00039##
(90) 3-(3-Chloro-4-(N-(prop-2-yn-1-yl)-3-((3,3,3-trifluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P9) was isolated (0.21 g, 72%).
(91) ##STR00040##
(92) 3-(4-(N-Ethyl-3-((3,3,3-trilluoropropyl)thio)propanamido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P18) was isolated (0.053 g, 20%)
(93) ##STR00041##
(94) 3-(3-Chloro-4-(N-ethyl-3-((3,3,3-trilluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound P36) was isolated (0.13 g, 43%).
(95) ##STR00042##
(96) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)thio)-N-ethylpropanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P48) was isolated (0.16 g, 58%).
(97) ##STR00043##
(98) 3-(3-Chloro-4-(N-ethyl-3-((4,4,4-trifluorobutyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P53) was isolated (0.22 g, 77%).
(99) ##STR00044##
(100) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)thio)-N-methylpropanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P56) was isolated (0.22 g, 81%).
(101) ##STR00045##
(102) 3-(3-Chloro-4-(N-methyl-3-((4,4,4-trifluorobutyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P62) was isolated (0.18 g, 64%).
(103) ##STR00046##
(104) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)thio)-N-(prop-2-yn-1-yl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P65) was isolated (0.24 g, 84%).
(105) ##STR00047##
(106) 3-(3-Chloro-4-(N-(prop-2-yn-1-yl)-3-((4,4,4-trifluorobutyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P71) was isolated (0.16 g, 55%).
(107) ##STR00048##
(108) 3-(4-(3-(((2,2-Difluorocyclopropyl)methyl)thio)-N-ethylpropanamido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P74) was isolated (0.19 g, 73%).
(109) ##STR00049##
(110) 3-(4-(N-Ethyl-3-((4,4,4-trifluorobutyl)thio)propanamido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P80) was isolated (0.13 g, 49%).
(111) ##STR00050##
(112) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)thio)-N-ethylpropanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound P92) was isolated (0.20 g, 70%).
(113) ##STR00051##
(114) 3-(3-Chloro-4-(N-ethyl-3-((4,4,4-trilluorobutyl)thio)propanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound P98) was isolated (0.23 g, 75%).
(115) ##STR00052##
(116) 3-(4-(N-Ethyl-2-methyl-3-((3,3,3-trilluoropropyl)thio)propanamido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA1) was isolated (0.036 g, 13%).
(117) ##STR00053##
(118) 3-(3-Chloro-4-(N-ethyl-2-methyl-3-((3,3,3-trifluoropropyl)thio) propanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound FA2) was isolated (0.093 g, 31%).
(119) ##STR00054##
(120) 3-(3-Chloro-4-(N-ethyl-2-methyl-3-((3,3,3-trifluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA3) was isolated (0.092 g, 32%).
(121) ##STR00055##
(122) 3-(3-Chloro-4-(2-methyl-N-(prop-2-yn-1-yl)-3-((3,3,3trifluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA4) was isolated (0.097 g, 33%).
(123) ##STR00056##
(124) 3-(3-Chloro-4-(N,2-dimethyl-3-((3,3,3-trifluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA5) was isolated (0.061 g, 22%).
Example 15
Preparation of 3-(3-chloro-4-(N-methyl-3-((3,3,3-trifluoropropyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound P2
(125) ##STR00057##
(126) A stirred suspension of 3-(3-chloro-4-(N-methyl-3-(3,3,3-trifluoropropyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (0.14 g, 0.35 mmol) in acetic acid (4.0 mL) was charged with sodium perborate tetrahydrate (0.058 g, 0.38 mmol) at room temperature. The reaction mixture was stirred at room temperature for 4 hours. The reaction mixture was diluted with EtOAc (20 mL), quenched with a saturated NaHCO.sub.3 solution (100 mL) slowly and the layers were separated. The aqueous layer was extracted with EtOAc (225 mL). The combined organic layer was washed with brine (220 mL) and was dried over solid Na.sub.2SO.sub.4, filtered, and concentrated. The crude residue was purified by flash column chromatography using 0-10% MeOH/CH.sub.2Cl.sub.2 to provide the title compound (0.079 g, 53%)
(127) The following molecules were made in accordance with the procedures disclosed in Example 15
(128) ##STR00058##
(129) 3-(3-chloro-4-(N-(prop-2-yn-1-yl)-3-((3,3,3-trifluoropropyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P10) was isolated (0.075 g, 48%).
(130) ##STR00059##
(131) 3-(4-(N-Ethyl-3-((3,3,3-trilluoropropyl)sulfinyl)propanamido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P19) was isolated (0.091 g, 62%).
(132) ##STR00060##
(133) 3-(3-Chloro-4-(N-ethyl-3-((3,3,3-trilluoropropyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound P37) was isolated (0.11 g, 71%).
(134) ##STR00061##
(135) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)sulfinyl)-N-ethylpropanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P49) was isolated (0.076 g, 50%).
(136) ##STR00062##
(137) 3-(3-Chloro-4-(N-ethyl-3-((4,4,4-trilluorobutyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P54) was isolated (0.082 g, 52%).
(138) ##STR00063##
(139) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)sulfinyl)-N-methyl propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P57) was isolated (0.075 g, 51%).
(140) ##STR00064##
(141) 3-(3-Chloro-4-(N-methyl-3-((4,4,4-trifluorobutyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P63) was isolated (0.071 g, 46%).
(142) ##STR00065##
(143) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)sulfinyl)-N-(prop-2-yn-1-yl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P66) was isolated (0.074 g, 48%).
(144) ##STR00066##
(145) 3-(3-Chloro-4-(N-(prop-2-yn-1-yl)-3-((4,4,4-trifluorobutyl)sulfinyl) propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P72) was isolated (0.097 g, 42%).
(146) ##STR00067##
(147) 3-(4-(3-(((2,2-Difluorocyclopropyl)methyl)sulfinyl)-N-ethylpropan-amido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P75) was isolated (0.10 g, 72%).
(148) ##STR00068##
(149) 3-(4-(N-Ethyl-3-((4,4,4-trilluorobutyl)sulfinyl)propanamido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound P81) was isolated (0.094 g, 62%).
(150) ##STR00069##
(151) 3-(3-Chloro-4-(3-(((2,2-difluorocyclopropyl)methyl)sulfinyl)-N-ethylpropanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound P93) was isolated (0.10 g, 64%).
(152) ##STR00070##
(153) 3-(3-Chloro-4-(N-ethyl-3-((4,4,4-trilluorobutyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound P99) was isolated (0.074 g, 45%).
(154) ##STR00071##
(155) 3-(3-Chloro-4-(N-ethyl-2-methyl-3-((3,3,3-trifluoropropyl)sulfinyl) propanamido)-1H-pyrazol-1-yl)-5-fluoropyridine 1-oxide (Compound FA6) was isolated (0.073 g, 44%)
(156) ##STR00072##
(157) 3-(3-Chloro-4-(2-methyl-N-(prop-2-yn-1-yl)-3-((3,3,3-trifluoropropyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA7) was isolated (0.13 g, 80%).
(158) ##STR00073##
(159) 3-(3-Chloro-4-(N,2-dimethyl-3-((3,3,3-trifluoropropyl)sulfinyl)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA8) was isolated (0.074 g, 48%).
(160) ##STR00074##
(161) 3-(3-Chloro-4-(N-ethyl-2-methyl-3-((3,3,3-trifluoropropyl)sulfinyl) propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA9) was isolated (0.13 g, 82%).
(162) ##STR00075##
(163) 3-(4-(N-Ethyl-2-methyl-3-((3,3,3-trifluoropropyl)sulfinyl)propanamido)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound FA10) was isolated (0.11 g, 75%).
Example 16
Preparation of 3-(3-chloro-4-(N-ethyl-3-((2,2,2-trifluoroethyl)thio)propanamido)-1H-pyrazol-1-yl)pyridine 1-oxide
Compound P50
(164) ##STR00076##
(165) To a suspension of 3-((2,2,2-trifluoroethyl)thio)propanoic acid (0.296 g, 1.57 mmol) in 1,2-dichloroethane (DCE, 10.5 mL) was added oxalyl chloride (0.160 mL, 1.83 mmol) and one drop of DMF. The acid failed to go completely into solution and DMF (0.5 mL) was added. The reaction was stirred for 1 hour and then concentrated. The residue was taken up in DCE (5 mL) and transferred to a flask (under N.sub.2, at room temperature) containing 3-(3-chloro-4-(ethylamino)-1H-pyrazol-1-yl)pyridine 1-oxide (0.250 g, 1.05 mmol) and DMAP (0.384 g, 3.14 mmol) in DCE (6 mL). The reaction was left to stir overnight. The reaction was diluted in CH.sub.2Cl.sub.2 (10 mL) and quenched with water (10 mL). The phases were mixed and then separated. The organic phase was washed with brine (210 mL) and then dried over Na.sub.2SO.sub.4, filtered, and concentrated. The resulting residue was purified via flash column chromatography using 0-30% MeOH/EtOAc as eluent followed by reverse phase flash column chromatography using 5-100% MeCN/water as eluent to afford the desired product as a white solid (0.044 g, 10%).
Example 17
Preparation of 3-(4-((tert-butoxycarbonyl)(prop-2-yn-1-yl)amino)-3-chloro-1H-pyrazol-1-yl)pyridine 1-oxide
Compound CA5
(166) ##STR00077##
(167) A stirred solution of tent-butyl (3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)(prop-2-yn-1-yl)carbamate (1.18 g, 3.57 mmol) (WO 2013/062981) in CH.sub.2Cl.sub.2 (25 mL) was charged with m-CPBA (0.861 g, 4.99 mmol) portionwise over 5 minutes at 0 C. under a N.sub.2 atmosphere. The reaction mixture was stirred at room temperature for 16 hours. The reaction mixture was concentrated. The crude residue was purified by flash column chromatography using 0-20% MeOH/EtOAc as eluent to afford the title compound (1.18 g, 95%): .sup.1H NMR (400 MHz, CDCl.sub.3) 8.65 (s, 1H), 8.14 (d, J=6.4 Hz, 1H), 8.01 (s, 1H), 7.59 (d, J=8.0 Hz, 1H), 7.36 (dd, J=8.0, 6.4 Hz, 1H), 4.34 (d, J=1.6 Hz, 2H), 2.30 (t, J=1.6 Hz, 1H), 1.46 (s, 9H); ESIMS m/z 349 ([M+H].sup.+).
(168) The following molecules were made in accordance with the procedures disclosed in Example 17:
(169) ##STR00078##
(170) 3-(4-((tert-Butoxycarbonyl)(ethyl)amino)-3-methyl-1H-pyrazol-1-yl)pyridine 1-oxide (Compound CA6) was isolated as an off-white solid from tert-butyl ethyl(3-methyl-1-(pyridin-3-yl)-1H-pyrazol-4-yl)carbamate (US 2012/0110702) (9.00 g, 85%): .sup.1H NMR (400 MHz, CDCl.sub.3) 8.68 (s, 1H), 8.08 (dd, J=8.4, 1.2 Hz, 1H), 7.74 (s, 1H), 7.56 (dd, J=8.4, 1.2 Hz, 1H), 7.31 (d, J=8.4, 1H), 3.56 (q, J=7.2 Hz, 2H), 2.22 (s, 3H), 1.44 (s, 9H), 1.14 (t, J=7.2 Hz, 3H); ESIMS m/z 319 ([M+H].sup.+).
(171) ##STR00079##
(172) 3-(4-((tert-Butoxycarbonyl)(methyl)amino)-3-chloro-1H-pyrazol-1-yl)pyridine 1-oxide (Compound CA7) was isolated from tert-butyl(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)(methyl)carbamate (US 2012/0110702) (1.10 g, 95%): .sup.1H NMR (400 MHz, CDCl.sub.3) 8.63 (s, 1H), 8.12 (d, J=6.4 Hz, 1H), 7.81 (s, 1H), 7.55 (d, J=8.0 Hz, 1H), 7.34 (dd, J=8.0, 6.4 Hz, 1H), 3.21 (s, 3H), 1.45 (s, 9H); ESIMS m/z 325 ([M+H].sup.+).
(173) ##STR00080##
(174) 3-(4-((tert-Butoxycarbonyl)(ethyl)amino)-3-chloro-1H-pyrazol-1-yl)-5-fluoropyridine1-oxide (Compound CA8) was isolated as an off-white solid from tert-butyl(3-chloro-1-(5-fluoropyridin-3-yl)-1H-pyrazol-4-yl)(ethyl)carbamate (US 2012/0110702) (2.80 g, 100%): .sup.1H NMR (400 MHz, CDCl.sub.3) 8.59 (s, 1H), 8.09 (t, J=2.0, 1.6 Hz, 1H), 7.86 (s, 1H), 7.48 (dd, J=8.4, 1.6 Hz, 1H), 3.60 (q, J=7.2 Hz, 2H), 1.45 (bs, 9H), 1.17 (t, J=7.2 Hz, 3H); ESIMS m/z 357 ([M+H].sup.+).
Example 18
Preparation of 3-((4,4,4-trifluorobutyl)thio)propanoic acid
Compound CA9
(175) ##STR00081##
(176) A stirred solution of 3-mercaptopropanoic acid (12.2 g, 37.6 mmol) in EtOH (40 mL) was charged with sodium hydroxide (3.31 g, 82.9 mmol) followed by addition of (10.8 g, 56.5 mmol) at room temperature. The reaction mixture was heated to reflux for 2 hours. The reaction mixture was concentrated. The obtained crude compound was diluted with water (50 mL) and was washed with methy tert-butylether (220 mL). The aqueous layer was acidified to pH 2 with a hydrochloric acid solution (2 N) and was extracted with EtOAc (2100 mL). The combined organic layer was washed with brine (120 mL) and was dried over anhydrous Na.sub.2SO.sub.4, filetered, and concentrated to afford the title compound as a colorless liquid (5.77 g, 71%): .sup.1H NMR (400 MHz, CDCl.sub.3) 10.0 (bs, 1H), 2.79 (dt, J=8.0, 0.8 Hz, 2H), 2.68-2.60 (m, 4H), 2.28-2.10 (m, 2H), 1.90-1.83 (m, 2H).
(177) The following molecules were made in accordance with the procedures disclosed in Example 18:
(178) ##STR00082##
(179) 2-Methyl-3-((3,3,3-trifluoropropyl)thio)propanoic acid (Compound CA10) was isolated as a colorless liquid (6.10 g, 75%): .sup.1H NMR (300 MHz, CDCl.sub.3): 2.95-2.85 (m, 1H), 2.76-2.41 (m, 4H), 2.43-2.34 (m, 2H), 1.31 (d, J=8.4 Hz, 3H).
Example 19
Preparation of 3-((4,4,4-trifluorobutyl)thio)propanoyl chloride
Compound CA11
(180) ##STR00083##
(181) A stirred solution of 3-(4,4,4-trifluorobutyl)thio)propanoic acid (1.50 g, 6.94 mmol) in CH.sub.2Cl.sub.2 (10 mL) was charged with oxalyl chloride (1.32 g, 10.4 mmol) dropwise at 0 C., followed by DMF (catalytic) and was stirred at room temperature for 2 hours. The reaction mixture was concentrated to afford the title compound as a liquid (1.62 g, 100%). The obtained acid chloride was directly used without characterization.
(182) The following molecules were made in accordance with the procedures disclosed in Example 19:
(183) ##STR00084##
(184) 2-Methyl-3-((3,3,3-trifluoropropyl)thio)propanoyl chloride (Compound CA12) was isolated as a liquid (1.62 g, 100%). The obtained acid chloride was directly used without characterization.
(185) TABLE 3 shows non-limiting examples of the 1-(3-pyridyl-N-oxide)pyrazole compounds of formula I, II, or III, or any agriculturally acceptable salt thereof. Compounds F1, F6, and F9 were prepared according to Example 10. Compounds F2, F5, and F10 were prepared according to Example 9. Compounds F4, F7, F8, F12, FAH, FAl2, FA13, and FA14 were prepared according to Example 4. Compound F11 was prepared according to Example 7. Compound F13 was prepared according to Example 12. Compounds P1, P9, P18, P36, P48, P53, P56, P62, P65, P71, P74, P80, P92, P98, FA1, FA2, FA3, FA4, and FA5 were prepared according to Example 14. Compounds P2, P10, P19, P37, P49, P54, P57, P63, P66, P72, P75, P81, P93, P99, FA6, FA7, FA8, FA9, and FA10 were prepared according to Example 15. Compound P50 was prepared according to Example 16.
(186) TABLE 4 and TABLE 5 show further non-limiting examples of the 1-(3-pyridyl-N-oxide)pyrazole compounds of formula I, II, or III, or any agriculturally acceptable salt thereof.
(187) TABLE-US-00003 TABLE 3 Appear- ance ESIMS .sup.13C NMR, No. Structure mp ( C.) (m/z) .sup.1H NMR .sup.19F NMR, IR F1
(188) TABLE-US-00004 TABLE 4 Prepared according to No. Structure Appearance Example: C1
(189) TABLE-US-00005 TABLE 5 May be Prepared according to No. Structure Example: P1
(190) While this invention has been described in certain embodiments, the present invention can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains and which fall within the limits of the appended claims.